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Background
The National Healthcare Safety Network (NHSN) 
is a public health surveillance system that the 
Centers for Disease Control and Prevention’s 
(CD C) Division o f Healthcare Quality Promotion 
(D H Q P) maintains and supports as a mainstay 
o f its healthcare-associated infection (HAI) 
prevention program . N H S N  is used by healthcare 
facilities in all 50 states; W ashington, D .C .; and 
Puerto Rico. As o f  December 2012, 30 states 
and W ashington, D .C . required, or have plans 
to require, use o f  N H S N  for state-specific HAI 
reporting mandates. Hospitals participating in 
the Centers for Medicare and M edicaid Services 
(CMS) Hospital Inpatient Quality Reporting 
(IQR) Program use N H S N  to report HAI data 
as part o f  the program’s requirements, including 
central line-associated bloodstream infections 
(CLABSI) among adult, pediatric, and neonatal 
intensive care unit patients beginning in January 
2011; in January 2012 required reporting of 
catheter-associated urinary tract infections 
(CAUTI) among adult and pediatric intensive 
care unit patients and surgical site infections (SSI) 
among colon surgery and abdominal hysterectomy 
patients began. The HAI data reported via N H SN  
to CM S are used to qualify hospitals for their 
annual paym ent update and for public reporting 
at the D epartm ent o f H ealth and H um an Services 
Hospital Com pare web site (1).
Since N H S N ’s inception in 2005, D H Q P  has 
used HAI data from the system for national-level 
analysis and reporting. Past reporting includes 
summary data that define the benchmarks used 
for inter-facility comparison (such as location- 
specific, device-associated infection rates) (2), risk 
adjustm ent models for surgical site infections (3), 
or summarized antimicrobial resistance data for 
each HAI type reported (4). Starting in 2009, 
summ ary measures o f HAIs, national and state- 
specific, were reported using the standardized 
infection ratio (SIR) (5). This current SIR report 
again provides a summ ary o f the characteristics
o f  facilities reporting to N H S N  by state and the 
key metrics o f the HAI experience for the United 
States in 2011. State-specific summ ary statistics 
are again presented for CLABSI in this report. 
However, this report expands upon the 2010 
SIR report to include national burden estimates 
for CLABSI among critical care patients and 
SSI among select surgical patients; the estimated 
average reim bursement paid by CM S attributable 
to a CLABSI also is presented. The goals o f  this 
report are to summarize available HAI data on 
CLABSIs, SSIs, and CAUTIs at the national level 
for 2011 and to provide an additional perspective 
on the progress o f HAI prevention nationally by 
comparison to the 2010 experience. This progress 
report also provides an indication o f  the extent 
to which HAI prevention goals established by the 
D epartm ent o f H ealth and H um an Services (HHS) 




This report presents data from HAI surveillance 
during calendar year 2011 that was reported either 
m andatorily or voluntarily to N H S N  from facilities 
across all 50 states, W ashington, D .C ., and Puerto 
Rico. D ata included in the report use N H SN  
definitions that have been in place since 2008 for 
CLABSI (6) and SSI (7) and 2009 for CAUTI 
(limited to symptomatic urinary tract infection)
(8). These definitions differ slightly from those in 
use as o f January 2013. Any data reported from 
non-acute care hospitals (e.g., long-term  care 
hospitals, rehabilitation hospitals), outpatient 
dialysis facilities or inpatient dialysis wards, long 
term  care facilities (e.g., skilled nursing facilities), 
and outpatient surgical settings were excluded from 
this report. D ata include all reports subm itted 
to N H S N  as o f September 4, 2012, allowing for 
a 9-m onth latency period to allow for complete 
reporting o f infection events and denom inator data 
through December 2011.
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Similar to previous reports, the HAI data are 
summarized across all patient care location types 
and also stratified into three m utually exclusive 
categories, by state: critical care units (ICUs), wards 
(for this report, wards also include step-down 
and specialty care areas [including hematology/ 
oncology and bone marrow transplant]), and 
neonatal intensive care units (including Level II/
III and Level III). Active efforts by C D C  and 
healthcare facilities reporting to N H S N  began 
in 2011 to more accurately categorize long-term 
care, long-term  acute care, and rehabilitation 
patient care locations that reside w ithin acute 
care hospitals; these locations were excluded from 
this report. Future reports will include these 
patient care locations and reflect more accurate 
categorization. Summary statistics o f reporting 
characteristics are presented both nationally and 
by state for each HAI included in the report. Data 
external to N H S N  were used to construct some 
o f these metrics. To approximate the num ber 
o f acute care hospitals in each state, C D C  used a 
list o f  all facilities that have been assigned a CMS 
Certification N um ber (C C N ), adjusted to account 
for multiple facilities reporting under the same 
C C N  and to include military and Veterans Affairs 
hospitals. Additionally, C D C  consulted w ith each 
state health departm ent to confirm the presence 
o f any m andatory requirements for reporting 
HAI data to N H S N  during 2010 and 2011 and 
to assess whether or no t the health departm ent 
has performed any internal or external validation 
studies o f N H S N  data that they have access to. 
Validation included data quality assessment for 
implausible values and detection o f  outlier facilities 
(e.g., high or low reported num ber o f infections, 
rates, denominators) along w ith more detailed 
evaluation by health departm ent staff w ith specific 
facilities and/or audits o f medical records. The 
SSI data included in this report include only the 
more comm only reported operative procedures 
and approximates those targeted for process-of-care 
improvements by the Surgical Care Im provement 
Project (SCIP), a national project led by CM S and 
CM S-funded Q uality Im provement Organizations
(Appendix A). SSI standardized infection ratios 
(SIRs) are reported for these procedure categories 
combined, as well as for each specific procedure 
category. O nly deep incisional and organ/space 
infections at the prim ary surgical site detected 
during the index hospital admission or upon 
readmission to the same hospital are included in 
the reported SIR data; superficial incisional SSIs 
and any SSIs identified through post-discharge 
surveillance were excluded from the SIR but 
included in the burden estimates (see below).
Summary HAI Data and Calculation of SIRs
The referent period for this report remains January 
2006 through December 2008 for CLABSI and 
SSI and calendar year 2009 for CA UTI, as in 
previous SIR reports (2, 9). The CLABSI and 
CA UTI SIRs presented in this report represent 
comparisons o f  an observed num ber o f  HAIs 
during each reporting period to the predicted 
num ber based on the rates o f  infections among all 
facilities during the referent period, adjusting for 
key covariates (10). A lthough over 40 patient care 
location types are included in the referent period, 
facilities have reported from location types not 
included in the referent period during 2010 and
2011. In such cases, the CLABSI and CAUTI 
SIRs in this report cannot include data from these 
newer location types.
The covariates used to predict CLABSIs and 
CAUTIs included type o f  patient care location, 
bed size o f the patient care location, and hospital 
affiliation w ith a medical school. For N ICU s, the 
pooled mean umbilical catheter-associated BSI 
rates and CLABSI infection rates w ithin each birth 
weight category were used to predict the num ber 
o f  device-associated BSIs from reporting facilities, 
referred to as CLABSIs for this report. Clinical 
sepsis (without laboratory-confirmed bloodstream 
infection) was not included in the calculations 
o f  CLABSI during either the reporting periods 
or referent period. CAUTIs from N IC U s are 
not reported to N H S N . For SSI SIRs, specific
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risk models were constructed that evaluated 
all available procedure-level risk factors (e.g., 
duration o f surgery, surgical w ound class, use of 
endoscopes, patient age, and patient assessment at 
tim e o f anesthesiology [ASA score], among others) 
to predict the risk o f deep incisional or organ/ 
space infections identified during admission or 
readmission to the same hospital (3).
For national and state SIRs, all eligible data were 
included and the total num ber o f infections 
predicted was compared to the num ber o f 
infections reported to N H S N  at each level o f 
aggregation. In state-specific reporting o f  CLABSI 
SIRs, an SIR is only produced if  at least 5 
facilities in a state reported any data for the given 
location category. Facility-specific SIRs were 
also calculated for each o f  the summ ary measures 
presented nationally. However, if  a single facility’s 
predicted num ber o f infections for a specific HAI 
type (e.g., CLABSI) was <1.0, a facility-specific 
SIR was not calculated for that HAI. Distributions 
o f facility-specific SIRs in national and state reports 
were produced only if  at least 20 facilities had at 
least one predicted infection for a given HAI type. 
Additionally, summ ary counts o f  facility-specific 
SIRs were produced at the national level. The 
num ber o f facilities that reported significantly 
fewer infections than what would be predicted and 
the num ber o f  facilities that reported significantly 
more infections than what would be predicted 
are shown for each location type and surgical 
procedure category.
An SIR that has a confidence interval (CI) that 
includes 1.0 should be interpreted as indicating 
that the num ber o f HAIs that an entity (e.g., 
healthcare facility, state) observed and reported to 
N H S N  is no different than if  its experience had 
been the same as the referent population. The 
CI around the SIR depends on several factors, 
including the num ber o f facilities reporting data 
from the relevant patient care location type or 
surgical procedure, the num ber o f device days 
or surgical procedures reported, and the types o f 
facilities reporting.
Serial Comparison of SIRs
Progress in preventing HAIs was evaluated by 
comparing the SIRs between 2010 and 2011. To 
fairly compare CLABSI and CA UTI SIRs, the 
patient care location rules used in this report (e.g., 
removal o f  data from long-term  acute care and 
rehabilitation facilities) were applied to 2010 data 
and 2010 SIRs were recalculated. This evaluation 
was first accomplished by comparing the SIRs 
between each o f the two sequential reporting 
periods for all data reported from all facilities. A 
second (sensitivity) analysis was then performed 
by restricting the facilities included to only 
those that reported during both 2010 and 2011, 
referred to as the change in SIR for continuously 
reporting facilities. A conditional binomial test 
was performed to assess for statistically significant 
changes in the pairs o f sequential SIRs for each 
level o f  aggregation (two-sided P-value less than 
or equal to 0.05). Because this report uses all data 
reported to N H S N  before September 4, 2012, 
calculations o f  2010 and 2011 SIRs will differ 
slightly from reports using datasets created earlier 
in time, including those created by individual state 
health departm ents for public reporting.
National Disease Burden Estimates
The calculation o f national estimates o f the 
num ber o f  CLABSIs in hospitalized critical 
care patients involved several data sources and 
steps. CM S Hospital Cost Reports from 1990 
through 2009 were used to obtain patient-days 
specifically occurring in critical care units in all 
Medicare-certified US hospitals (11), stratified by 
m ajor hospital types: small (<200 beds) teaching, 
m edium  (201-500 beds) teaching, large (>500 
beds) teaching, small non-teaching, m edium  non­
teaching, and large non-teaching. Because Federal 
hospitals do not file Hospital Cost Reports with 
CM S, we inflated patient-day estimates by between 
5% and 10%, based on a weighted estimate o f 
the annual ratio o f all patient-days to non-Federal 
patient-days reported to the American Hospital 
Association (12). Based on historic secular trends
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we used linear regression to project critical care 
patient-days to 2011 (2009 was the m ost recent 
complete data year) and to generate standard errors 
around annual patient-day estimates for these six 
acute care hospital types.
To apply overall critical care CLABSI rates 
to these denominators, we constructed a negative 
binomial model for each hospital type based on 
data reported to N H S N  from critical care units 
and generated estimated critical care CLABSI rates 
(per 1,000 patient-days) for 2011. To address 
differences between the types o f  hospitals reporting 
to N H S N  and all hospitals nationally, an average 
o f the six predicted CLABSI rates was calculated 
for 2011, weighted by the estimated num ber of 
national critical care patient-days occurring in 
each o f  the six hospital types (i.e., the rates were 
standardized to the estimated national distribution 
o f critical care patient-days by hospital type).
The total num ber o f CLABSIs in 2011 was 
calculated by applying estimated CLABSI rates 
to the estimated num ber o f  critical care patient- 
days nationally for 2011. We used M onte Carlo 
simulation to quantify the uncertainty around 
these estimates. Input distributions were created 
using predicted values and standard errors from 
the linear models (patient-days and federal 
inflation factor) and negative binomial models 
(CLABSI rates) described above. We sampled 
values from each o f the input distributions in 
10,000 simulation cycles and used the sampled 
values to calculate CLABSI estimate for each 
cycle. We calculated 95%  credible intervals based 
on the 2.5 th  and 97.5th  percentiles o f all output 
distributions. Analyses were conducted using SAS 
version 9.1 (© 2002-2010, SAS Institute Inc., Cary, 
N C ) and @Risk for Excel version 5.7 (©2010, 
Palisade Corp., Ithaca, NY).
Estim ating SSIs for the U.S. in 2011 was 
performed using the procedure-specific crude 
infection rates for both deep incisional and organ/ 
space infections as well as superficial infections and
included infections detected after discharge among 
the SCIP procedures. These rates were extrapolated 
to the entire U nited States using estimates o f 
the total num ber o f procedures performed from 
the 2010 National Inpatient Sample (NIS), and 
adjusted to account for federal facilities performing 
procedures but no t represented in the NIS.
Attributable Medicare Reimbursement 
for CLABSIs
Confirm ed CLABSI cases from eight states 
reporting to N H S N  were linked to claim records 
in the Medicare Provider Analysis and Review 
(MedPAR) database using hospital admission 
date, date o f  birth, sex, and facility. For both data 
sources, we lim ited the population to those over 
the age o f  64 w ith a valid date o f  admission from 
January 2008 through December 2009, a valid 
date o f birth, sex, and facility. In the M edPAR file, 
patients were also lim ited to those who aged into 
the cohort w ith or w ithout end stage renal disease, 
enrolled in Medicare Part A and B throughout 
their eligibility, and never enrolled in a Medicare 
Advantage (H M O ) program. Facility locations 
between N H S N  and M edPAR were linked using 
an algorithm that m atched data from the N H S N  
facility file and the CM S Cost Reports from 2004­
2009. To link, first, the frequency o f  combinations 
o f  admission date, date o f birth, sex, and facility 
was determ ined for each data source. I f  a particular 
com bination occurred more than once in either 
data source, those observations would no longer 
be considered for linking. O nce each data source 
contained a unique set o f records based on those 
combinations o f variables, the two data sources 
were linked through those variables. O nly exact 
matches were included.
Using this linked dataset, we performed a 
retrospective cohort study comparing hospitalized 
patients who had a CLABSI to patients who 
did not. The prim ary outcom e was Medicare 
reim bursement for the hospitalization. Frequency 
m atching and multivariate regression were
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employed to control for potential confounders.
For this analysis, five non-CLABSI control stays 
were selected such that the frequency o f prim ary 
IC D -9-C M  procedure category, which we found 
to be a valid predictor o f length o f stay, and ICU  
care were similar between CLABSI stays and non- 
CLABSI stays. The reim bursement attributable to 
CLABSI was estimated as the difference in medians 
between exposed and unexposed using multivariate 
median regression. M ultivariate models included 
terms for age, race, sex, m orbidity score, num ber 
o f secondary procedures prior to infection, CMS 
wage index, CM S case mix index, facility bed size, 
teaching status, and num ber o f  critical care beds. 
Presence o f  an IC D -9-C M  procedure code for 




Tables 1a, 1b, and 1c summarize the extent o f HAI 
reporting to N H S N  and variability in reporting 
o f CLABSI, CA UTI, and SSI by state. In 2011, 
CLABSI data were reported by facilities in all 50 
states, W ashington, D .C ., and Puerto Rico. All 
states had at least five facilities report CLABSI 
data to N H SN . As a result o f  the CM S Inpatient 
Q uality Reporting Program’s requirem ent for 
reporting o f CLABSI data in ICUs to N H S N , a 
large num ber o f facilities began reporting CLABSI 
data for the first tim e in 2011, w ith 3,472 facilities 
reporting compared to 2,242 in 2010 (an increase 
o f 55%). Facilities reported CLABSI data from 
12,122 patient care locations in 2011 (5,722 
[47%] IC U , 5,436 ward [45%], 964 [8%] N IC U ). 
CAUTI data were reported by 1,807 facilities in 
all 50 states, W ashington, D .C ., and Puerto Rico 
in 2011. O nly three states had fewer than five 
facilities report CAUTI data. CAUTI reporting 
increased by 84%  from 2010 (981 facilities 
reporting) to 2011. 6,402 different patient care 
locations reported CAUTI data to N H S N  in 2011 
(2,633 [41%] IC U , 3,769 [59%] ward). SSI data 
was reported from 2,130 facilities from 48 states
and W ashington, D .C . in 2011, an increase o f 
53% from the 1,388 facilities reporting SSI data 
in 2010. Seven states had fewer than  five facilities 
report SSI data during 2011. The num ber o f 
surgical procedures from the eligible categories 
increased by 40%  from 2010 to 2011, with 
748,192 procedures reported in 2011, compared to 
533,269 in 2010.
National Metrics
National metrics summarizing the HAI experience 
across the U nited States are displayed in Table
2. The overall CLABSI SIR uses data from all 
patient care locations eligible for this report 
combined, including ICUs, wards, and N IC U s (as 
defined in the M ethods). D uring 2011, 18,113 
CLABSIs from these locations were reported to 
N H S N  compared to 30,616.6 CLABSIs that 
were predicted based on experience in the referent 
population. The resulting SIR o f 0.592 (95% CI
0.583-0.600) translates to an approximate national 
reduction in the occurrence o f  CLABSIs from the 
referent period o f  41% . Facility-specific SIRs were 
calculated for 2,335 facilities reporting sufficient 
denom inators to predict at least one CLABSI.
H a lf o f facilities reported SIRs less than 0.469 (the 
median), and 90%  o f  facilities reported SIRs less 
than 1.280. W hen tests o f statistical significance 
were applied, 518 (22%) had an SIR that was 
statistically significantly less than 1.0 and 54 (2%) 
had an SIR statistically significantly greater than
1.0. W hen national SIRs were stratified by each o f 
the three location categories, the lowest SIR was 
found in ICUs (SIR = 0.557), followed by wards 
(SIR = 0.642), and then N IC U s (SIR = 0.645).
All three o f the location category-specific SIRs are 
lower than those reported in the 2010 SIR report. 
Four facilities only reported CLABSI data from 
location types that were not available during the 
referent period; these facilities are excluded from 
the analysis in Table 2.
7
D uring 2011, facilities reported 14,315 CAUTIs 
to N H S N  from patient care locations eligible for 
inclusion in this report, compared to 15,398.1 
predicted based on the experience in the referent 
population. The resulting SIR was 0.930 
(95% CI 0.914-0.945), translating into a 7%  
reduction in CAUTIs from 2009, the referent 
period for CAUTI. The SIR in IC U  locations 
(SIR 0.989, 95%  CI 0.969-1.010) was not 
statistically significant, indicating that there has 
been no reduction or increase in CAUTIs in ICUs 
compared to the referent period. The SIR from 
ward locations during 2011 (SIR 0.845, 95%  CI
0.823-0.868) was lower than the SIR from ICU  
locations, and is statistically significant, showing 
a reduction in CAUTIs in wards o f about 15% 
from the referent period. O f  the 1,307 facilities 
that reported enough data to predict at least one 
CAUTI during 2011, 172 (13%) had an overall 
CAUTI SIR significantly less than 1.0 and 133 
(10%) had an overall SIR significantly greater than
1.0.
The national SSI SIR for the SCIP procedures 
(Appendix A) was calculated for all o f  the 
procedure categories com bined as well as by 
individual N H S N  procedure categories. For the
I
 com bined national SSI SIR, 6,357 deep incisional
and organ/space infections found during admission 
or on readmission to the same hospital were 
identified following 748,192 procedures. Based 
on the various patient and procedural risk factors 
reported in association w ith these procedures, 
7,682.6 SSIs were predicted, resulting in an 
SIR o f 0.827 (0.807, 0.848). This translates to
I
 approximately a 17% reduction in these SSIs
among these procedure categories. In the facility- 
specific overall SSI SIR distribution, 90%  of 
facilities reported an SIR less than 1.716, slightly 
improved from 2010 where the 90th  percentile 
value was 1.813. There were 1,221 facilities with 
at least one predicted SSI; 141 (12%) had an SIR 
statistically significantly lower than 1.0 and 51 
(4%) had an SIR statistically significantly greater 
than 1.0.
In the procedure-specific SSI SIRs, the num ber 
o f  facilities reporting data and the num ber o f 
procedures reported varied widely among the 
N H S N  procedure categories. Knee arthroplasty 
was the m ost comm only reported procedure, with 
1,505 facilities reporting 264,155 procedures.
Very little reporting was done for rectal surgery, 
abdominal aortic aneurysm repair, and peripheral 
vascular bypass surgery, w ith 260, 165, and 100 
facilities reporting, respectively. The procedure- 
specific SIRs range from 0.543 to 0.896. N ine o f 
the ten procedure-specific SIRs were significantly 
lower than 1.0, w ith vaginal hysterectomy being 
the lone exception (SIR 0.867, 95%  CI 0.710­
1.048).
State Metrics
State-specific CLABSI SIR data from 2011 are 
presented in Table 3, stratified by location category.
For CLABSIs from all locations (Table 3a), SIRs 
for all 50 states, W ashington, D .C ., and Puerto 
Rico could be calculated: 49 o f  these jurisdictions 
had an overall CLABSI SIR that was significantly 
less than 1.0. All 50 states, W ashington, D .C ., 
and Puerto Rico had sufficient reporting from 
IC U  locations to calculate CLABSI SIRs from 
ICUs (Table 3b): 47 o f these jurisdictions had a 
CLABSI SIR from ICUs that was significantly less 
than 1.0. Fewer data were available from wards 
(Table 3c) and N IC U s (Table 3d). SIRs that were 
significantly less than  1.0 were reported from wards 
in 30 states and N IC U s in 28 states. Overall and 
location-specific CLABSI SIRs and their 95%  CIs 
(by state) are summarized in Table 4.
State Specific Progress in CLABSI 
Prevention
Serial SIRs for states w ith sufficient data to produce 
an overall CLABSI SIR in both 2010 and 2011 
are presented in Table 5. Four o f the 52 reporting 
jurisdictions did not have sufficient data to 
report serial CLABSI SIRs. O f  the remaining 48 
jurisdictions, 30 had no change in the CLABSI 
SIR from 2010 to 2011 and 18 reported a decrease
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in CLABSI SIR from 2010 to 2011. O f  these 18 
jurisdictions, 15 retained a significant decrease in 
CLABSI SIR when the analysis was restricted to 
continuously reporting facilities. No jurisdictions 
reported an increase in CLABSI SIR between the 
two reporting periods when assessing data from 
all reporting facilities. O ne state with no change 
in CLABSI SIR in all reporting facilities from 
2010 to 2011 had an increasing CLABSI SIR in 
continuously reporting facilities.
National Progress
Table 6 presents serial SIRs for national CLABSI, 
CA UTI, and SSI data for 2011 compared to 2010. 
For CLABSI, the SIR significantly decreased for 
the com bined all-location metric, as well as each 
o f the three location category-specific SIRs (ICUs, 
wards, and NICUs) in all reporting facilities; each 
o f these decreases was confirmed in continuously 
reporting facilities. There was no significant 
change in the overall CA UTI SIR for all reporting 
facilities between 2010 and 2011, bu t when the 
analysis was restricted to facilities who had reported 
in both 2010 and 2011, there was a significant 
decrease in the overall CA UTI SIR. For location- 
specific SIRs there was a significant decrease in 
the SIR among ward locations, bu t no change for 
critical care locations. These findings persisted 
when restricting to continuously reporting 
facilities. SIRs were significantly lower in 2011 
compared to 2010 for the com bined SSI SIR and 
for five o f the procedure-specific SIRs. However, 
when only continuously reporting facilities were 
assessed, these decreases persisted only for the 
com bined SSI SIR and knee arthroplasties.
Estimated Burden of Disease and 
Attributable Reimbursement in 2011
In 2011, the total num ber o f critical care patient- 
days was estimated at 21.9 million (95% CI, 20 .3­
23.5 million), w ith an estimated 12,400 CLABSIs 
(95% CI, 11,500-13,300) occurring among critical 
care patients. The total num ber o f superficial 
incisional, deep incisional, and organ/space SSIs
that occurred among the estimated 3,011,412 
(95% CI: 2,745,643-3,277,181) m ajor (i.e. SCIP) 
surgical procedures in 2011 was 52,567 (45,332­
60,844).
The attributable reim bursement (adjusted to 
2011 dollars using the Em ploym ent Cost Index 
for all civilian employees working in hospitals) 
by CM S to hospitals per CLABSI was estimated 
to be $26,109 (95% CI, $22,885 - $29,330). 
A ttributable reim bursement was not calculated for 
SSIs.
Discussion
The HAI data summarized in this report 
demonstrate that healthcare facilities reporting 
to N H S N  during 2011, as a group, reported 
fewer CLABSIs (41%), CAUTIs (7%), and SSIs 
(17%) than predicted based on the case-mix 
o f  patients and locations that were monitored. 
Moreover, CLABSI prevention success improved 
between reporting periods, as the SIR during 
2011 was significantly lower compared to the 
previous year (2010: SIR 0.68, 32%  reduction). 
Improved prevention success was evident in all 
location groups (critical care, ward, and N ICU ) 
for CLABSI. Im provem ent was more m odest for 
SSIs, for which the overall SSI SIR decreased from
0.93 to 0.83, but was not evident for all o f  the 
procedure types and only for knee arthroplasty 
when lim ited to continuous reporters. O f  note, 
in 2011 a substantial proportion o f all procedures 
included in this report were reported by facilities in 
California as they began to report for the first tim e 
in response to a state-wide mandate. M easuring 
progress between the two years therefore may be 
better assessed by focusing on the continuous 
reporters. The experience in CAUTI prevention is 
less clear. A lthough there were modest reductions 
in the SIR between 2010 and 2011, the decrease 
was driven by the 550 facilities reporting CAUTI 
from wards during both 2010 and 2011. In 
contrast, there was essentially no significant 
difference in the SIRs in critical care locations
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between the two periods. The lack o f  significant 
reductions in CAUTI SIRs may be due to lack 
o f substantial progress in critical care areas, an 
inability to substantially decrease catheter days in 
critical care areas (as can be done more easily in 
wards), or both o f these factors. However, at least 
one state, M ichigan, has seen a 25%  reduction in 
CAUTI using a device-day rate based SIR after 
im plem enting a series o f prevention initiatives. 
This suggests that w ith continued prevention 
efforts, we should expect continued reductions in 
both critical care and ward-specific CAUTI SIRs 
using a device-day methodology as described in 
this report (13).
This SIR report is the first to provide some 
perspective on the potential improvements that 
can occur w ith facility-specific engagement.
For each major location group and procedure 
category, roughly 2-9%  o f the facilities reported 
SIRs significantly greater than 1.0. A lthough the 
specific num ber o f facilities represented by this 
group varies between HAI type and procedure 
(e.g., 54 facilities for CLABSI, 133 for CAUTI,
25 for hip arthroplasty, 30 for knee arthroplasty, 
20 for colon surgery, and 15 for abdominal 
hysterectomy), it is a relatively small num ber of 
facilities compared to total num ber o f facilities 
reporting in 2011 (e.g., 3,468 reporting CLABSI, 
1,802 reporting CA UTI, 2,130 reporting SSIs). 
Focusing efforts on these outlier facilities may 
be one strategy to focus prevention resources in 
coming years, although m ost efficient methods 
to target prevention activities to make substantial 
reductions nationally are still being explored.
Overall compared to the previous year, there was 
an increase o f about 1,200 facilities reporting 
CLABSI, 900 facilities reporting CA UTI, and 700 
facilities reporting SSI. This dram atic increase is 
mostly the result o f  new reporting requirements 
for hospitals participating in C M S’s Hospital 
IQ R  Program, requiring participating facilities to 
report to CM S, through N H S N , IC U  CLABSIs
starting in 2011 and CAUTI and SSI beginning 
in 2012(1). Summary data reported through 
N H S N  to CM S as part o f this program  and 
posted quarterly on the CM S Hospital Com pare 
website are a subset o f  the data reported here (some 
facilities report to N H S N  but do not participate in 
the IQ R  Program); therefore the sum m ary statistics 
are expected to vary slightly.
Using the most recent data available in N H SN , 
we estimated 12,400 CLABSIs (95% CI, 11,500­
13,300) occurred among critical care patients in 
2011; the estimated total num ber o f superficial 
incisional, deep incisional, or organ/space SSIs that 
occurred in 2011 (among the estimated 3,011,412 
surgical procedures evaluated) was 52,567 (45,332­
60,844). These infections cost CM S approximately 
$26,000 per CLABSI occurring in IC U  patients. 
The attributable reim bursement from SSIs has 
not been determ ined to date. Also, because 
the distribution o f m ajor payer categories (i.e. 
Medicare, private insurance, and Medicaid) among 
patients w ith CLABSIs is unknown, we could 
not estimate the num ber o f  infections and total 
reimbursements attributable to these infections 
separately by major payer categories. W hile 
approximately 39%  o f all hospital costs result from 
care to Medicare beneficiaries, another 16% result 
from care provided under M edicaid and 35%  from 
beneficiaries o f private payers (14). Meanwhile, 
the per-infection reimbursements from private 
payers are likely to be considerably higher than that 
from Medicare and M edicaid (15). Thus, simply 
multiplying the point estimate o f the burden 
o f  IC U  CLABSIs by the attributable Medicare 
reim bursement per infection, while equaling 
approximately $322 million, likely underestimates 
the national total reimbursements attributable to 
these infections and borne by all th ird  party payers.
Regarding CLABSI prevention success regionally, 
almost all o f  the jurisdictions w ith sufficient 
data had overall CLABSI SIRs significantly 
less than 1.0 in 2011, confirming that national
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prevention progress has not been lim ited to select 
geographic areas. Prevention success was slightly 
less widespread in wards and N ICU s, although 
progress was evident in the m ajority o f jurisdictions 
for these locations as well. Furthermore, m ost of 
these jurisdictions reported accelerated prevention 
success in 2011 compared to 2010.
A major consideration for interpretation of 
these data and for future reports is assessing the 
confidence in the validity o f the data reported. 
Com pletion o f validation studies o f CLABSI data 
was reported from 25 states during 2011 (up from 
21 in 2010); evaluations included data quality 
assessment o f missing or implausible values and/ 
or detection o f outlier facilities (e.g., num ber o f 
infections, rates, denominators) in all 25 states, 
and audit o f  medical records in 14. Such validation 
studies occurred for CAUTI in 8 states, and for 
SSI in 15 states. All states provided information 
about any HAI validation activities that they 
have performed. Some states w ithout m andatory 
reporting o f a given HAI have performed 
validation on N H S N  data that are voluntarily 
shared with them  by facilities. Validation efforts by 
state departm ents o f health represent an im portant 
step toward a more complete understanding o f the 
HAI data reported to N H SN .
Regardless o f  the success o f  validation efforts, 
inherent variability in case-finding o f HAIs will 
occur between facilities, explaining some o f 
the differences in observed infection rates and 
facility-specific SIRs. Several efforts are in place 
to improve the accuracy and confidence in these 
HAI data. Web-based N H S N  surveillance training 
modules are now available (http://www.cdc.gov/ 
nhsn/training.htm l), which include webinars, 
slidesets, and self-paced, interactive, online training 
courses with continuing education credits available 
upon successful completion o f an assessment. 
N H S N  training is regularly provided during C D C - 
hosted events and at professional meetings and 
conferences. Improvements to the N H S N  system 
to improve data accuracy continue to be made,
including business rules and cross-field edit checks 
to prevent data entry errors, system alerts to inform 
users o f missing data, and data quality reports to 
inform  users o f  aberrant data.
As part o f  the National Action Plan to Prevent 
Healthcare-Associated Infections that was 
established in 2008, H H S has set goals for 
reducing CLABSI, CA UTI, and SSI by December 
2013 (16). The data included in this report 
indicate that steady progress is occurring towards 
the goal o f  a 50% reduction in CLABSI over the 
course o f 5 years (we report a 41%  reduction 
from baseline in the th ird  year) and the 25%  
reduction goal for SSI (we report a 17% reduction 
from baseline in the th ird  year). Progress towards 
the 25%  reduction goal for CAUTI is moving 
more slowly, w ith a 7%  reduction from baseline 
in 2011 (this is the second year o f measurement 
w ith a baseline year o f 2009), bu t w ith sustained 
prevention efforts, the 2013 goal remains 
attainable.
The SIRs summarize complex data related to HAIs 
in a single set o f indicators that use national data 
for a specified tim e period as a com m on referent 
group. The indirect standardization technique used 
to calculate SIRs is also used in the calculation o f 
standardized m ortality ratios (SMRs), a commonly 
used m ethod in epidemiology for comparing 
m ortality between a group and a referent 
population. This summ ary measure should not 
be used to derive any absolute ranking o f facilities, 
states, or regions, bu t rather as a tool to identify 
facilities, states, or regions that may deserve 
targeted evaluations, which may include validation 
efforts or assessing potential prevention programs.
As more data is now available, improved m ethods 
o f  risk adjusting HAI data are being explored, 
including direct standardization o f data reported 
comprehensively, the use o f  reliability adjusted 
SIRs, and additional measures o f CAUTI 
prevention (such as a patient-day based rate). 
M easuring progress and performance from a single
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surveillance system has inherent challenges that 
we are com m itted to overcoming. Future reports 
will incorporate these new developments as we 
continue to explore the value and feasibly o f 
applying new m ethods and operations to N H S N  
surveillance methodology and analysis.
such prevention. Publication o f this report is one 
step among many in providing data needed for 
analysis and action at all levels, w ith the intent 
o f  spurring additional progress toward HAI 
elimination throughout the United States.
Conclusion
This report presents a set o f national summary 
statistics for CLABSIs, CAUTIs, and SSIs for 
2011, including serial SIRs for CLABSI, CAUTI, 
and SSI for 2010-2011. As a single summary 
measure o f  prevention success, there has been 
a large reduction (41%) in CLABSIs among 
reporting hospitals compared to predictions, w ith 
more modest reductions seen for CAUTI (7%) 
and SSI (17%). Prevention success improved 
in 2011 compared to 2010 for CLABSI. For 
SSI, improved prevention success over the two 
years was docum ented among five o f the nine 
operative procedures evaluated, bu t the impact 
o f new reporters in 2011 greatly influenced this 
observation. Overall, there is still substantial 
opportunity  for improvement across a range o f 
operative procedures. Additional progress can 
be made in CAUTI prevention, for which most 
o f the national prevention success was lim ited to 
ward locations. Analyses using the CLABSI SIR 
at the state level, including serial comparisons 
o f SIRs, provide a m ethod for m onitoring the 
impact o f interventions and assessing the success 
o f state-based and national HAI reduction efforts. 
As SSI and CA UTI reporting becomes more 
comprehensive in 2012, future SIR reports will 
include state-specific metrics for these HAIs as well. 
Ongoing interactions w ith state health departments 
will be critical in determ ining ways to improve the 
reporting o f HAIs and ways to act on these data to 
prevent HAIs. The remaining burden from these 
HAIs, in terms o f both num bers o f  infections (and 
the implicit associated m orbidity and mortality) 
and increased reimbursements attributable to these 
infections highlights the ongoing need for HAI 
prevention as well as the data required to support
12
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Table la . Characteristics o f  facilities reporting to NH SN  by State1, 2010 and 2011: Central Line-associated Bloodstream Infections (CLABSI)2
2010 2011
Healthcare Facilities Reporting to N HSN Healthcare Facilities Reporting to N HSN































Total ICU Wards2 N IC U 8
Alaska 26 0 1-4 <20.0 81.3 4 3 0 1 0 9 34.6 70.8 30 9 19 2
Alabama 118 0 69 58.5 45.8 157 112 38 7 74 Yes 77 65.3 88.4 185 130 41 14
Arkansas 87 0 21 24.1 52.5 40 29 7 4 45 Yes 47 54.0 82.5 93 61 24 8
Arizona 97 0 21 21.6 56.0 60 43 15 2 0 58 59.8 86.5 142 93 39 10
California 417 M 339 81.3 74.3 2,102 537 1,439 126 389 Yes1 350 83.9 87.1 2,237 538 1,565 134
Colorado 94 58 Yes1 51 54.3 80.5 98 64 17 17 59 Yes 51 54.3 93.7 119 68 33 18
Connecticut 41 30 Yes1 30 73.2 91.5 41 38 0 3 30 Yes1 30 73.2 85.8 67 54 2 11
D.C. 12 M Yes 9 75.0 43.4 34 23 6 5 10 Yes1 8 66.7 96.5 33 20 7 6
Delaware 13 8 Yes 8 61.5 85.5 19 13 4 2 8 Yes1 8 61.5 93.8 20 13 5 2
Florida 237 0 Yes 45 19.0 52.5 158 81 68 9 0 187 78.9 88.1 633 390 199 44
Georgia 166 0 35 21.1 68.5 148 67 69 12 0 104 62.7 87.2 331 182 114 35
Hawaii 27 0 7 25.9 51.8 14 8 6 0 14 15 55.6 85.5 34 22 10 2
Iowa 122 0 24 19.7 41.2 38 28 8 2 0 40 32.8 82.4 72 45 16 11
Idaho 47 0 1-4 <10.0 41.7 5 2 2 1 0 12 25.5 80.3 30 19 3 8
Illinois 207 149 Yes1 147 71.0 87.7 345 227 80 38 186 Yes1 150 72.5 84.2 395 227 129 39
Indiana 148 0 32 21.6 49.6 89 47 36 6 0 88 59.5 88.9 248 131 90 27
Kansas 149 0 13 8.7 70.7 37 25 9 3 0 Yes 43 28.9 81.9 90 64 16 10
Kentucky 116 0 21 18.1 70.3 67 45 18 4 0 71 61.2 80.9 169 126 30 13
Louisiana 172 0 30 17.4 51.3 85 43 32 10 0 73 42.4 86.2 189 112 50 27
Massachusetts 95 73 Yes1 70 73.7 95.1 150 122 18 10 72 Yes 69 72.6 90.5 192 124 58 10
Maryland 59 45 Yes1 47 79.7 81.7 140 84 39 17 45 Yes1 47 79.7 87.9 168 88 63 17
Maine 41 0 6 14.6 79.3 27 12 14 1 0 22 53.7 86.6 58 30 25 3
Michigan 157 0 49 31.2 71.0 143 100 34 9 0 94 59.9 88.0 261 174 68 19
Minnesota 144 0 1-4 <10.0 61.9 7 6 1 0 0 50 34.7 83.5 94 74 11 9
Missouri 135 0 10 7.4 92.7 25 18 3 4 0 76 56.3 88.8 170 125 27 18
Mississippi 111 0 13 11.7 78.6 74 27 41 6 0 43 38.7 87.4 137 67 56 14
Montana 64 0 10 15.6 72.5 27 11 13 3 0 12 18.8 94.5 32 13 14 5
Table la . Characteristics o f  facilities reporting to NH SN by Statel, 2010 and 2011: Central line-associated Bloodstream Infections (CLABSI)2
2010 2011
Healthcare Facilities Reporting to N HSN Healthcare Facilities Reporting to N HSN































Total ICU Wards2 N IC U 8
North Carolina 133 0 Yes1 37 27.8 65.8 156 79 69 8 0 Yes1 93 69.9 84.8 350 173 153 24
North Dakota 48 0 1-4 <10.0 70.8 8 3 4 1 0 6 12.5 92.1 21 11 4 6
Nebraska 95 0 9 9.5 66.9 34 11 21 2 0 19 20.0 89.9 71 26 38 7
New Hampshire 29 25 Yes1 24 82.8 86.0 31 26 5 0 26 Yes 24 82.8 91.4 35 27 5 3
New Jersey 94 72 Yes1 72 76.6 98.4 159 136 3 20 72 Yes 72 76.6 96.7 179 137 20 22
New Mexico 48 0 Yes1 18 37.5 57.1 49 24 23 2 0 Yes1 30 62.5 89.6 67 34 29 4
Nevada 46 M 17 37.0 38.4 61 33 25 3 28 Yes1 23 50.0 93.0 147 46 92 9
New York 251 182 Yes1 180 71.7 92.6 584 366 164 54 177 Yes1 177 70.5 92.8 714 367 294 53
Ohio 203 0 26 12.8 73.2 107 59 38 10 0 134 66.0 87.2 388 257 106 25
Oklahoma 144 51 50 34.7 91.4 104 70 31 3 51 Yes1 54 37.5 87.6 130 79 43 8
Oregon 64 42 Yes 48 75.0 83.5 77 59 17 1 44 Yes 44 68.8 88.5 87 59 21 7
Pennsylvania 221 221 Yes1 179 81.0 83.3 1,424 317 1,061 46 221 Yes 178 80.5 86.6 1,350 301 1,003 46
Puerto Rico 59 0 0 0.0 0 19 32.2 72.2 102 37 60 5
Rhode Island 14 0 1-4 <30.0 40.8 10 6 3 1 0 11 78.6 92.0 27 19 7 1
South Carolina 81 79 Yes1 63 77.8 87.2 400 101 298 1 80 Yes1 67 82.7 88.7 410 105 295 10
South Dakota 64 0 1-4 <10.0 38.9 3 2 1 0 0 13 20.3 70.2 43 21 18 4
Tennessee 154 80 Yes1 82 53.2 79.0 291 168 96 27 80 Yes 96 62.3 89.0 329 166 139 24
Texas 506 0 80 15.8 44.5 197 131 47 19 M 266 52.6 85.1 655 423 119 113
Utah 53 0 1-4 <10.0 13.9 3 2 1 0 26 25 47.2 92.2 50 36 1 13
Virginia 109 77 Yes1 80 73.4 85.9 202 138 58 6 78 Yes 81 74.3 92.7 224 141 58 25
Vermont 16 8 8 50.0 94.2 10 10 0 0 8 8 50.0 95.5 11 10 0 1
Washington 103 62 Yes1 63 61.2 93.3 111 81 14 16 62 Yes1 62 60.2 95.4 124 80 28 16
Wisconsin 144 0 Yes1 42 29.2 55.2 171 61 102 8 0 Yes1 78 54.2 86.2 239 97 124 18
West Virginia 58 37 Yes 38 65.5 70.8 104 55 48 1 37 39 67.2 87.9 114 59 52 3
Wyoming 31 0 0 0.0 0 19 61.3 50.3 26 12 13 1
Table lb . Characteristics o f  facilities reporting to NH SN by State1, 2010 and 2011: Catheter-associated Urinary Tract Infections (CAUTI)2
2010 2011



































Alaska 26 0 1-4 <10.0 100.0 1 1 0 0 5 19.2 51.4 6 4 2
Alabama 118 0 84 71.2 42.3 216 32 184 91 Yes1 95 80.5 90.6 243 42 201
Arkansas 87 0 6 6.9 55.8 10 5 5 0 33 37.9 53.8 64 39 25
Arizona 97 0 6 6.2 36.4 27 13 14 0 19 19.6 68.9 59 30 29
California 417 0 70 16.8 75.8 241 95 146 0 101 24.2 78.5 425 138 287
Colorado 94 0 22 23.4 58.8 49 32 17 0 37 39.4 80.4 84 45 39
Connecticut 41 0 1-4 <10.0 77.4 7 7 0 0 6 14.6 41.7 13 13 0
D.C. 12 0 1-4 <30.0 35.8 10 5 5 0 1-4 <40.0 78.8 11 5 6
Delaware 13 0 1-4 <20.0 73.1 9 6 3 0 7 53.8 92.1 19 11 8
Florida 237 0 Yes 29 12.2 45.7 122 55 67 0 Yes1 99 41.8 66.3 353 175 178
Georgia 166 0 17 10.2 82.8 83 38 45 0 58 34.9 78.3 170 95 75
Hawaii 27 0 1-4 <10.0 81.3 4 2 2 0 9 33.3 72.7 18 9 9
Iowa 122 0 Yes 42 34.4 30.3 64 21 43 0 Yes1 52 42.6 85.8 82 29 53
Idaho 47 0 1-4 <10.0 58.3 4 2 2 0 7 14.9 85.1 14 10 4
Illinois 207 0 23 11.1 82.5 101 46 55 0 55 26.6 66.8 195 97 98
Indiana 148 0 Yes 33 22.3 51.0 94 35 59 0 63 42.6 81.0 189 89 100
Kansas 149 0 11 7.4 78.4 27 23 4 0 Yes 41 27.5 75.7 73 50 23
Kentucky 116 0 12 10.3 72.3 44 29 15 0 33 28.4 82.4 120 60 60
Louisiana 172 0 12 7.0 60.4 44 18 26 0 29 16.9 69.2 78 45 33
Massachusetts 95 0 10 10.5 78.6 14 10 4 0 14 14.7 52.5 34 18 16
Maryland 59 0 12 20.3 63.4 33 24 9 0 28 47.5 71.6 116 56 60
Maine 41 0 1-4 <10.0 92.6 18 5 13 0 6 14.6 86.5 39 12 27
Michigan 157 0 21 13.4 74.4 75 37 38 0 34 21.7 79.4 104 56 48
Minnesota 144 0 1-4 <10.0 66.7 3 2 1 0 6 4.2 81.5 9 8 1
Missouri 135 0 5 3.7 89.9 14 10 4 0 18 13.3 66.4 32 22 10
Mississippi 111 0 5 4.5 91.4 35 16 19 0 23 20.7 72.9 97 45 52
Montana 64 0 9 14.1 81.9 24 9 15 0 12 18.8 92.5 40 12 28
Table lb . Characteristics o f facilities reporting to NH SN by State 1, 2010 and 2011: Catheter-associated Urinary Tract Infections (CAUTI)2
2010 2011



































North Carolina 133 0 Yes1 20 15.0 70.6 84 36 48 0 Yes1 35 26.3 71.9 166 60 106
North Dakota 48 0 1-4 <10.0 68.3 5 1 4 0 1-4 <10.0 76.4 12 5 7
Nebraska 95 0 5 5.3 77.3 25 7 18 17 17.9 88.5 61 20 41
New Hampshire 29 0 1-4 <20.0 38.3 10 3 7 0 5 17.2 85.4 12 6 6
New Jersey 94 72 Yes 72 76.6 96.5 142 128 14 72 Yes 72 76.6 97.2 152 129 23
New Mexico 48 0 1-4 <10.0 41.7 5 4 1 0 13 27.1 50.6 15 10 5
Nevada 46 0 9 19.6 41.4 34 17 17 0 16 34.8 77.7 94 38 56
New York 251 0 53 21.1 84.6 143 122 21 0 80 31.9 81.7 352 171 181
Ohio 203 0 11 5.4 84.8 61 26 35 0 40 19.7 78.8 177 70 107
Oklahoma 144 0 32 22.2 83.2 70 36 34 0 34 23.6 83.7 73 38 35
Oregon 64 0 15 23.4 92.9 39 21 18 0 22 34.4 90.6 62 33 29
Pennsylvania 221 221 Yes1 189 85.5 88.7 1,459 315 1,144 221 Yes 190 86.0 90.6 1,405 302 1,103
Puerto Rico 59 0 0 0.0 0 18 30.5 78.4 97 36 61
Rhode Island 14 0 0 0.0 0 8 57.1 93.7 21 16 5
South Carolina 81 0 5 6.2 80.4 23 6 17 0 25 30.9 48.6 97 36 61
South Dakota 64 0 1-4 <10.0 38.9 3 2 1 0 10 15.6 54.5 26 9 17
Tennessee 154 0 9 5.8 78.7 41 23 18 0 26 16.9 61.6 96 40 56
Texas 506 0 17 3.4 38.9 58 28 30 0 120 23.7 57.6 276 171 105
Utah 53 0 0 0.0 0 5 9.4 67.6 9 6 3
Virginia 109 0 23 21.1 74.3 123 51 72 0 37 33.9 83.0 134 76 58
Vermont 16 0 1-4 <10.0 97.2 3 3 0 0 1-4 <10.0 100.0 3 3 0
Washington 103 0 27 26.2 87.1 49 37 12 0 39 37.9 80.0 83 51 32
Wisconsin 144 0 24 16.7 60.6 123 32 91 0 Yes 45 31.3 87.0 167 46 121
West Virginia 58 0 12 20.7 71.5 66 17 49 0 28 48.3 82.5 94 33 61
Wyoming 31 0 0 0.0 0 24 77.4 21.2 31 13 18
Table 1c. Characteristics o f  facilities reporting to N H SN  by State1, 2010 and 2011: Surgical Site Infections9
2010 2011
Healthcare Facilities Reporting 
to NHSN
























Alaska O . . 1-4 3S.9 82
Alabama 64 4O.9 7,539 Yes Yes 74 S5.6 15,267
Arkansas 6 54.2 S62 11 53.O 1,505
Arizona 6 7O.S 3,7S9 14 56.6 4,824
California 63 62.S 23,4S7 M Yes 332 73.S 136,576
Colorado Yes Yesa 61 91.5 29,S13 Yes Yesa 61 93.3 29,590
Connecticut 1-4 SS.9 1,791 1-4 S1.3 1,968
D.C. 1-4 55.6 1,25O 1-4 SO.6 832
Delaware M 6 4S.6 6O7 Yes 6 S4.7 3,234
Florida 25 65.O 7,496 66 47.9 11,576
Georgia 2O 66.3 S,7O4 32 5S.9 10,208
Hawaii O . . 1-4 12.5 12
Iowa 1-4 S9.6 936 6 6S.1 1,122
Idaho 1-4 72.2 647 Yesa 11 61.4 1,221
Illinois M Yes 131 71.6 3O,762 Yes Yesa 137 SS.9 39,109
Indiana 6 75.O 3,324 22 42.4 4,807
Kansas S 7O.S 2,7O2 Yes 12 5S.3 3,687
Kentucky 1-4 94.4 1,73S 7 33.3 1,676
Louisiana 5 75.O 1,S14 15 33.3 1,879
Massachusetts Yes Yesa 67 96.S 36,411 Yes Yes 67 93.4 35,945
Maryland M Yesa 45 55.7 14,OO2 Yes Yes 45 97.6 23,981
Maine 1-4 1OO.O 1,265 1-4 79.2 847
Michigan 25 S1.O 14,41O 2S S6.9 15,938
Minnesota 6 4S.6 2,S49 5 9O.O 3,582
Missouri 6 93.1 2,914 15 44.4 2,486
Mississippi 1O 76.7 3,751 15 61.7 5,021
Montana 5 45.O 2,6O3 S 72.9 3,061
North Carolina 2O 77.1 5,672 32 62.O 7,299
North Dakota 1-4 5O.O 314 O . .
Nebraska 1-4 95.S S36 1O 35.O 1,379
New Hampshire Yes Yesa 26 93.9 7,O16 Yes Yes 26 91.O 6,9S6
New Jersey Yes Yes 72 97.O 29,SO1 Yes Yes 71 97.O 2S,9S2
New Mexico 1-4 1OO.O 4S 5 3S.3 1O3
Nevada S 44.S 1,9O6 Yes 11 72.7 4,553
New York Yes Yesa 179 97.4 61,3S3 Yes Yesa 17S 97.2 63,S55
Ohio S S9.6 4,9OO 12 77.1 5,253
Oklahoma S S4.4 4,2OO 23 71.4 4,76O
Oregon Yes Yesa 5O SS.S 2O,61S Yes 53 93.4 27,641
Pennsylvania Yes Yesa 166 94.3 97,244 Yes 171 93.2 99,OO1
Puerto Rico O . . O . .
Rhode Island O . . O . .
South Carolina Yes Yesa 59 92.1 26,596 Yes Yesa 59 96.3 26,956
South Dakota O . . 6 3O.6 1O6
Tennessee Yes Yes 6S 63.9 16,42S Yes Yes SO S5.4 24,6S2
Texas 25 34.3 2,725 Yes 247 42.S 26,651
Utah O . . 1-4 12.5 33
Virginia 1S 57.9 3,661 24 44.4 3,57O
Vermont Yes 13 9S.1 2,715 Yes 13 94.2 2,924
Washington 44 SO.5 27,166 42 9O.7 3O,139
Wisconsin 32 63.S 14,137 Yes 47 S4.O 21,31S
West Virginia 5 5S.3 579 1O 6O.O 1,7S3
Wyoming 1-4 66.7 21S 1-4 41.7 1S2
All U.S. 13SS 79.7 533,629 2,13O 76.6 74S,192
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Table 1 Footnotes:
1. United States, Washington, D .C ., and Puerto Rico
2. D ata included in this report are from 2010 and 2011 from acute care facility ICUs (critical care units), N ICU s (see footnote 
8), and wards (for this report wards also include step-down and specialty care areas [hematology/oncology, bone marrow 
transplant]). Long term acute care facilities and locations, inpatient rehabilitation facilities and locations, dialysis facilities 
and locations, and long term care facilities (skilled nursing facilities) are no t included in this report.
3. The num ber of acute care facilities in a state was obtained using a list o f facilities with Centers for Medicare and Medicaid 
Services Certification Numbers (CCNs) which was last updated on June 1, 2012. Acute care facilities for which data is 
included in this report (children’s, critical access, psychiatric, and acute short stay hospitals) were identified in the file and 
counted. Facilities sharing the same C C N  in the N H SN  database were identified and added to the count from the C C N  file. 
M ilitary and VA hospitals were identified using the 2009 American Hospital Association survey of healthcare facilities and 
added to the count from the C C N  file. Long term acute care facilities, inpatient rehabilitation facilities, and long term care 
facilities (skilled nursing facilities) were excluded from the count. Because of this methodology, this count may differ slightly 
from counts provided by state regulatory authorities.
4. The num ber of acute care facilities eligible to report the HAI type under a state mandate, for states in which a mandate exists 
to report that HAI type to the state health departm ent using N H S N  at the beginning of each reporting period. This number 
is reported to C D C  by the state health department. If  no state mandate existed at the beginning of a reporting period, this 
num ber is zero. If no mandate existed at the beginning o f the reporting period, but was implemented during the reporting 
period, the value of this column is “M ” for midyear implementation. Since state mandates regarding surgical procedures vary 
greatly by procedure type, the presence or absence of a mandate involving any surgical procedure for acute care facilities is 
indicated by Yes/No.
5. Yes indicates that the state health department reported the completion of either or both of the following validation studies of 
N H S N  data reported during the reporting period: data quality assessment o f missing or implausible values along with state 
health departm ent followup with identified facilities, and detection of outlier facilities along with state health department 
followup with identified facilities. Yesa indicates that the state completed one or both of these activities and also conducted 
an audit o f medical records (although intensity of auditing activities [i.e., num ber o f facilities audited and num ber o f medical 
records reviewed] varies by state). Information on validation efforts was requested from all states, regardless o f the presence of 
a legislative mandate for the particular HAI type. Some states w ithout m andatory reporting of a given HAI to the state health 
departm ent have performed validation on N H S N  data that is voluntarily shared with them by facilities.
6. This measure is calculated using multiple data sets. It is calculated by dividing “No. of Healthcare Facilities Reporting to 
N H S N ” by “No. o f Facilities in State,” and multiplying by 100. The denom inator comes from the process described in 
footnote 3 above. The num erator comes from the N H SN  system, and includes all facilities for which data were reported for 
at least one m onth during the 12 m onth reporting period. For CLABSI, this does not include facilities for which zero central 
line days were reported for all 12 months; for CAUTI this does not include facilities for which zero urinary catheter days were 
reported for all 12 months; for SSI, this does not include facilities for which zero of the selected procedures were performed 
for all 12 months. In states w ith a mandate to report HAI data using N H SN , some facilities in the count of facilities in the 
state might not be included in the mandate (e.g., facilities do not have the units or perform the procedures covered by the 
mandate; or the mandate covers only facilities above a certain bed size); or, some facilities included in the mandate m ight have 
reported zero central line days, zero urinary catheter days, or zero o f the procedure types performed for the full 12-month 
period.
7. This metric is the rate at which facilities submitted data to N H S N  during the reporting period. It is calculated by dividing 
the num ber of m onths of data subm itted to N H SN  by the total num ber of m onths o f data eligible to be submitted, and 
multiplying by 100. For CLABSI or CAUTI, a m onth in which zero device days were reported is not counted in the 
numerator; for SSI, a m onth in which zero o f the procedure types were performed is not counted in the numerator. For SSI, 
this is calculated by dividing the num ber of m onths that at least 1 procedure was reported to N H S N  by the total number 
of months any procedure could have been reported, multiplied by 100. For example, if  a state has two facilities reporting to 
N H SN , then 24 total months of data could have been submitted to N H S N  in a 12-month period. If  those two facilities sent 
in 24 total m onths o f data, the state participation percent is 100%. If  one facility subm itted data for 8 months and the other 
for 4 months, then the state participation percent is 50% (data were reported for 12 of 24 total months). For states with a 
mandate, it is possible for this percentage to be less than 100 for several reasons, including that some facilities reporting might 
not be covered by the mandate, m ight only be submitting selected m onths o f data, or m ight not have had any central line 
days, urinary catheter days or procedures in a given m onth  to report.
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8. N IC U  locations included are those classified by N H S N  C D C  location codes as Level II/III and Level III neonatal critical 
care areas. A Level II/III neonatal critical care area is defined by N H S N  as a combined nursery housing both Level II and 
III newborns and infants. A Level III neonatal critical care area is defined by N H S N  as a hospital N IC U  organized with 
personnel and equipm ent to provide continuous life support and comprehensive care for extremely high-risk newborn infants 
and those with complex and critical illness. Level III is subdivided into four levels differentiated by the capability to provide 
advanced medical and surgical care.
9. SSIs included are those following select surgical procedures approximating procedures covered by SCIP, using NHSN-defined 
SSIs that were classified as deep incisional or organ/space, and were detected during admission or upon readmission. The 
SCIP procedures are listed in Appendix A.
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Table 2 . N atio n al S tandardized In fectio n  R atios (SIR s) an d  facility-specific sum m ary  SIRs u sing  H A I d ata  
rep o rted  from  all N H SN  facilities rep o rtin g  d u rin g  2 0 1 1  by  H A I an d  p a tien t p o p u la tio n s 
C en tral L ine-associated B loodstream  Infections (CLABSIs), C atheter-associated U rinary  Tract Infections (C A U TIs), 
an d  Surgical Site Infections (SSIs) follow ing Surgical Care Im provem ent P roject (S C IP ) Procedures





No. of Infections 
Observed Predicted SIR
95% Cl for SIR 





















CLABSI, all4 3,468 18,113 30,615.577 0.592 0.583 0.600 2,335 518 22% 54 2% 0.000 0.171 0.469 0.825 1.280
ICUs5 3,321 10,134 18,208.687 0.557 0.546 0.567 2,170 368 17% 41 2% 0.000 0.100 0.438 0.835 1.329
Wards6 1,252 5,781 8,998.281 0.642 0.626 0.659 793 151 19% 20 3% 0.000 0.156 0.484 0.863 1.372
NICUs7 928 2,198 3,408.609 0.645 0.618 0.672 594 61 10% 10 2% 0.000 0.178 0.564 0.999 1.539
CAUTIs, all8 1,802 14,315 15,398.109 0.930 0.914 0.945 1,307 172 13% 133 10% 0.000 0.228 0.675 1.237 1.892
ICUs5 1,536 8,925 9,021.342 0.989 0.969 1.010 1,051 82 8% 109 10% 0.000 0.239 0.726 1.360 2.053
Wards6 973 5,390 6,376.767 0.845 0.823 0.868 696 86 12% 60 9% 0.000 0.200 0.644 1.118 1.871
No. o f Procedures
SSI, combined SCIP procedures5 2,130 748,192 6,357 7,682.638 0.827 0.807 0.848 1,221 141 12% 51 4% 0.000 0.327 0.715 1.156 1.716
SSI, Hip arthroplasty 1,355 181,758 1,456 1,624.199 0.896 0.851 0.944 497 18 4% 24 5% 0.000 0.234 0.709 1.316 1.920
SSI, Knee arthroplasty 1,505 264,115 1,426 1,663.435 0.857 0.813 0.903 540 21 4% 30 6% 0.000 0.000 0.659 1.325 1.971
SSI, Coronary artery bypass graft10 553 88,225 837 1,074.975 0.779 0.727 0.833 360 23 6% 15 4% 0.000 0.000 0.631 1.172 1.770
SSI, Cardiac surgery 317 29,175 154 220.605 0.698 0.592 0.817 62 2 3% 2 3% 0.000 0.000 0.635 1.276 1.735
SSI, Peripheral vascular bypass surgery 100 3,558 78 104.646 0.745 0.589 0.930 33 0 0% 1 3% 0.000 0.000 0.752 1.094 1.392
SSI, Abdominal aortic aneurysm repair 165 1,218 12 22.102 0.543 0.313 0.880 2 0 0% 0 0%
SSI, Colon surgery 1,150 69,872 1,679 2,108.745 0.796 0.759 0.835 553 39 7% 20 4% 0.000 0.127 0.647 1.138 1.746
SSI, Rectal surgery 260 3,643 77 103.555 0.744 0.587 0.929 22 4 18% 1 5% 0.000 0.000 0.386 0.854 1.516
SSI, Abdominal hysterectomy 1,223 83,540 531 636.954 0.834 0.764 0.908 193 1 1% 17 9% 0.000 0.000 0.695 1.246 2.220
SSI, Vaginal hysterectomy 528 23,088 107 123.422 0.867 0.710 1.048 29 0 0% 1 3% 0.000 0.000 0.727 1.412 1.714
Table 2  Footnotes
1. Facility-specific SIR data is only displayed for a location group or procedure category if  >5 facilities reported during the 
reporting period.
2. Facility-specific key percentiles were only calculated if >20 facilities had >1.0 predicted HAI during the reporting period. If  a 
single facility’s predicted num ber o f HAIs (e.g., CLABSI) was <1.0, a facility-specific SIR was neither calculated nor included 
in the determinations of the distribution of facility-specific SIRs.
3. Percent of facilities with at least one predicted infection who had an SIR significantly less than or greater than 1.0.
4. D ata from all ICUs, wards (and other non-critical care locations), and NICUs. This excludes LTAC locations (or facilities) 
and inpatient rehabilitation locations (or facilities).
5. D ata from all ICUs; excludes wards (and other non-critical care locations), NICUs, LTAC locations (or facilities), and
inpatient rehabilitation locations (or facilities).
6. D ata from all wards (for this table wards also include stepdown and specialty care areas [including hematology/oncology, bone 
marrow transplant]. This excludes LTAC locations [or facilities] and inpatient rehabilitation locations [or facilities]).
7. D ata from all N IC U  locations, including Level II/III and Level III nurseries. For purposes o f this report, both umbilical-line
and central-line associated bloodstream infections are considered CLABSIs.
8. D ata from all ICUs and wards (and other non-critical care locations). This excludes NICUs, LTAC locations (or facilities) and 
inpatient rehabilitation locations (or facilities).
9. SSIs included are those following select surgical procedures approximating procedures covered by SCIP, using N H S N  surgical 
procedure categorizations that were classified as deep incisional or organ/space, and detected upon admission or readmission. 
(Specific N H SN  procedures and the corresponding SCIP procedures are listed in Appendix A.)
10. Coronary artery bypass graft includes procedures with either chest only or chest and donor site incisions.
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Table 3. State-specific Standardized Infection Ratios (SIRs) and facility-specific SIR summary measures, NH SN  facilities reporting during 2011












95% Cl for SIR Facility-specific SIRs at Key Percentile*4




Alaska 9 27 37.712 0.716 0.472 1.042
Alabama Yes Yes 77 342 492.973 0.694 0.622 0.771 0.097 0.212 0.636 0.889 1.698
Arkansas Yes Yes 47 151 313.916 0.481 0.407 0.564 0.000 0.206 0.453 0.786 1.527
Arizona 58 270 469.599 0.575 0.508 0.648 0.000 0.000 0.395 0.679 0.965
California Yes Yes1 350 2,806 4,963.174 0.565 0.545 0.587 0.000 0.179 0.457 0.839 1.296
Colorado Yes Yes 51 213 363.025 0.587 0.511 0.671 0.000 0.206 0.404 0.783 0.963
Connecticut Yes Yes1 30 159 253.459 0.627 0.534 0.733 0.000 0.256 0.517 0.904 1.309
D.C. Yes Yes1 8 117 168.799 0.693 0.573 0.831
Delaware Yes Yes1 8 50 93.553 0.534 0.397 0.705
Florida 187 1,048 1,939.236 0.540 0.508 0.574 0.000 0.170 0.457 0.755 1.151
Georgia 104 693 848.860 0.816 0.757 0.880 0.000 0.359 0.603 0.939 1.299
Hawaii Yes 15 21 81.440 0.258 0.160 0.394
Iowa 40 71 128.037 0.555 0.433 0.699 0.000 0.000 0.000 0.258 0.800
Idaho 12 25 58.433 0.428 0.277 0.632
Illinois Yes Yes1 149 623 1,050.639 0.593 0.547 0.641 0.000 0.000 0.451 0.896 1.384
Indiana 88 411 708.300 0.580 0.526 0.639 0.000 0.000 0.348 0.508 0.885
Kansas Yes 43 94 216.413 0.434 0.351 0.532
Kentucky 71 249 346.779 0.718 0.632 0.813 0.000 0.000 0.382 0.829 0.921
Louisiana 73 298 409.713 0.727 0.647 0.815 0.000 0.086 0.649 0.956 1.400
Massachusetts Yes Yes 68 320 569.091 0.562 0.502 0.627 0.000 0.000 0.503 0.792 1.100
Maryland Yes Yes1 47 297 443.061 0.670 0.596 0.751 0.000 0.144 0.462 0.944 1.489
Maine 22 96 97.054 0.989 0.801 1.208
Michigan 94 317 875.392 0.362 0.323 0.404 0.000 0.029 0.221 0.495 0.777
Minnesota 50 104 257.782 0.403 0.330 0.489 0.000 0.160 0.300 0.436 0.655
Missouri 76 256 546.609 0.468 0.413 0.529 0.000 0.000 0.298 0.651 0.852
Mississippi 43 178 293.906 0.606 0.520 0.701 0.000 0.313 0.524 0.690 1.347
Montana 12 24 58.859 0.408 0.261 0.607
Table 3. State-specific Standardized Infection Ratios (SIRs) and facility-specific SIR summary measures N H SN facilities reporting during 2011












95% Cl for SIR Facility-specific SIRs at Key Percentile*4




North Carolina Yes1 93 511 894.276 0.571 0.523 0.623 0.000 0.000 0.394 0.716 0.899
North Dakota 6 21 56.270 0.373 0.231 0.571
Nebraska 19 129 211.439 0.610 0.509 0.725
New Hampshire Yes Yes 24 35 54.651 0.640 0.446 0.891
New Jersey Yes Yes 72 422 579.844 0.728 0.660 0.801 0.000 0.337 0.632 1.122 1.697
New Mexico Yes1 30 83 158.810 0.523 0.416 0.648
Nevada Yes Yes1 23 299 518.123 0.577 0.514 0.646
New York Yes Yes1 177 1,626 1,943.724 0.837 0.796 0.878 0.281 0.446 0.781 1.100 1.720
Ohio 134 542 1,147.145 0.472 0.434 0.514 0.000 0.134 0.353 0.667 0.981
Oklahoma Yes Yes1 54 194 377.196 0.514 0.444 0.592 0.000 0.000 0.227 0.546 1.230
Oregon Yes Yes 44 75 195.277 0.384 0.302 0.481 0.000 0.000 0.228 0.451 0.857
Pennsylvania Yes Yes 177 1,256 2,590.605 0.485 0.458 0.512 0.000 0.197 0.422 0.728 1.098
Puerto Rico 19 198 140.632 1.408 1.219 1.618
Rhode Island 11 52 73.210 0.710 0.530 0.931
South Carolina Yes Yes1 66 538 761.846 0.706 0.648 0.768 0.139 0.351 0.608 0.912 1.563
South Dakota 13 29 65.442 0.443 0.297 0.636
Tennessee Yes Yes 96 652 932.237 0.699 0.647 0.755 0.000 0.317 0.546 1.026 1.389
Texas Yes 266 1,073 1,919.930 0.559 0.526 0.593 0.000 0.000 0.427 0.808 1.187
Utah Yes 25 113 167.951 0.673 0.554 0.809
Virginia Yes Yes 81 447 638.340 0.700 0.637 0.768 0.000 0.223 0.495 1.008 1.398
Vermont 8 6 24.388 0.246 0.090 0.535
Washington Yes Yes1 62 178 373.103 0.477 0.410 0.553 0.000 0.093 0.303 0.642 1.022
Wisconsin Yes1 78 258 449.368 0.574 0.506 0.649 0.000 0.046 0.467 0.862 1.037
West Virginia Yes 39 113 245.591 0.460 0.379 0.553 0.000 0.000 0.141 0.590 1.071
Wyoming 19 3 10.366 0.289 0.060 0.846
All US 3,468 18,113 30,615.577 0.592 0.583 0.600 0.000 0.171 0.469 0.825 1.280
Footnotes for Table 3a
1. D ata from all ICUs, wards (and other non-critical care locations), and NICUs. This excludes LTAC locations (or facilities) 
and inpatient rehabilitation locations (or facilities).
2. Yes indicates the presence of a state mandate to report CLABSI data from any location to N H S N  at the beginning of 2011.
3. Yes indicates that the state health department reported the completion of either or both of the following validation studies 
of N H SN  CLABSI data reported from any location during the reporting period: data quality assessment o f missing or 
implausible values along with state health department followup with identified facilities, and detection of outlier facilities 
along w ith state health department followup w ith identified facilities. Yesa indicates that the state completed one or both 
of these activities and also conducted an audit o f medical records. Information on validation efforts was requested from 
all states, regardless o f the presence of a legislative mandate for the particular HAI type and location. Some states without 
m andatory reporting of a given HAI to the state health departm ent have performed validation on N H SN  data that is 
voluntarily shared with them by facilities.
4. Facility-specific key percentiles were only calculated if >20 facilities had >1.0 predicted HAI during the reporting period. If  a 
single facility’s predicted num ber o f HAIs (e.g., CLABSI) was <1.0, a facility-specific SIR was neither calculated nor included 
in the determinations of the distribution of facility-specific SIRs.
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Table 3. State-specific Standardized Infection Ratios (SIRs) and facility-specific SIR summary measures, NH SN  facilities reporting during 2011












95% Cl for SIR Facility-specific SIRs at Key Percentiles4




Alaska 8 10 14.787 0.676 0.324 1.244
Alabama Yes Yes 74 208 359.328 0.579 0.503 0.663 0.045 0.216 0.472 1.120 2.001
Arkansas Yes Yes 43 100 207.440 0.482 0.392 0.586 0.000 0.000 0.408 0.786 1.674
Arizona 57 213 360.114 0.591 0.515 0.676 0.000 0.000 0.353 0.679 1.076
California Yes Yes1 317 1,051 1,944.915 0.540 0.508 0.574 0.000 0.074 0.453 0.829 1.414
Colorado Yes Yes 49 111 211.399 0.525 0.432 0.632 0.000 0.138 0.339 0.644 0.936
Connecticut Yes Yes1 30 113 208.046 0.543 0.448 0.653 0.000 0.264 0.529 0.892 1.309
D.C. Yes Yes1 8 87 114.812 0.758 0.607 0.935
Delaware Yes Yes1 8 40 69.632 0.574 0.410 0.782
Florida 183 752 1,421.509 0.529 0.492 0.568 0.000 0.088 0.423 0.769 1.155
Georgia 102 394 550.737 0.715 0.646 0.790 0.000 0.222 0.478 0.917 1.304
Hawaii Yes 14 8 63.550 0.126 0.054 0.248
Iowa 35 60 91.776 0.654 0.499 0.842
Idaho 11 15 43.740 0.343 0.192 0.566
Illinois Yes Yes1 146 391 639.980 0.611 0.552 0.675 0.000 0.000 0.506 0.934 1.517
Indiana 83 159 382.642 0.416 0.353 0.485 0.000 0.000 0.321 0.470 0.875
Kansas 42 52 150.337 0.346 0.258 0.454
Kentucky 71 180 273.347 0.659 0.566 0.762 0.000 0.000 0.358 0.801 0.984
Louisiana 69 199 278.348 0.715 0.619 0.821 0.000 0.388 0.687 1.025 1.500
Massachusetts Yes Yes 67 203 402.526 0.504 0.437 0.579 0.000 0.000 0.476 0.802 1.107
Maryland Yes Yes1 47 226 302.475 0.747 0.653 0.851 0.000 0.000 0.478 0.957 1.534
Maine 22 45 44.331 1.015 0.740 1.358
Michigan 91 215 666.756 0.322 0.281 0.369 0.000 0.000 0.224 0.466 0.584
Minnesota 48 93 230.664 0.403 0.325 0.494 0.000 0.155 0.300 0.485 0.655
Missouri 75 191 416.144 0.459 0.396 0.529 0.000 0.000 0.223 0.743 1.043
Mississippi 42 106 161.280 0.657 0.538 0.795 0.000 0.260 0.511 0.876 1.492
Montana 11 17 23.072 0.737 0.429 1.180
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95% Cl for SIR Facility-specific SIRs at Key Percentiles4




North Carolina Yes1 87 275 505.157 0.544 0.482 0.613 0.000 0.000 0.319 0.707 0.998
North Dakota 6 10 39.504 0.253 0.121 0.466
Nebraska 19 48 79.909 0.601 0.443 0.796
New Hampshire Yes Yes 24 25 45.169 0.553 0.358 0.817
New Jersey Yes Yes 72 322 466.765 0.690 0.617 0.769 0.000 0.252 0.608 1.138 1.697
New Mexico Yes1 27 43 82.254 0.523 0.378 0.704
Nevada Yes Yes1 22 126 251.114 0.502 0.418 0.597
New York Yes Yes1 177 802 1,148.246 0.698 0.651 0.749 0.233 0.381 0.682 1.024 1.591
Ohio 134 368 827.977 0.444 0.400 0.492 0.000 0.063 0.362 0.683 0.993
Oklahoma Yes Yes1 52 121 255.077 0.474 0.394 0.567 0.000 0.000 0.183 0.452 0.924
Oregon Yes Yes 43 63 156.767 0.402 0.309 0.514 0.000 0.000 0.295 0.402 0.855
Pennsylvania Yes Yes 157 483 1,073.668 0.450 0.411 0.492 0.000 0.062 0.424 0.722 1.165
Puerto Rico 19 113 83.865 1.347 1.110 1.620
Rhode Island 10 43 60.013 0.717 0.518 0.965
South Carolina Yes Yes1 55 177 269.510 0.657 0.564 0.761 0.000 0.000 0.582 1.059 1.704
South Dakota 12 11 30.711 0.358 0.179 0.641
Tennessee Yes Yes 93 371 506.675 0.732 0.660 0.811 0.000 0.357 0.620 1.104 1.737
Texas Yes 264 787 1,453.983 0.541 0.504 0.580 0.000 0.000 0.381 0.827 1.193
Utah Yes 25 60 111.883 0.536 0.409 0.690
Virginia Yes Yes 81 269 405.529 0.663 0.586 0.748 0.000 0.247 0.481 0.987 1.399
Vermont 8 6 19.784 0.303 0.111 0.660
Washington Yes Yes1 62 113 260.523 0.434 0.357 0.521 0.000 0.000 0.334 0.597 1.086
Wisconsin Yes1 69 164 275.599 0.595 0.507 0.693 0.000 0.224 0.462 0.930 1.169
West Virginia Yes 38 92 157.339 0.585 0.471 0.717
Wyoming 12 3 7.982 0.376 0.078 1.098
All US 3,321 10,134 18,208.687 0.557 0.546 0.567 0.000 0.100 0.438 0.835 1.329
Footnotes for Table 3b
1. D ata from all ICUs; excludes wards (and other non-critical care locations), NICUs, LTAC locations (or facilities), and 
inpatient rehabilitation locations (or facilities).
2. Yes indicates the presence of a state mandate to report CLABSI data from any IC U  to N H SN  at the beginning o f 2011.
3. Yes indicates that the state health department reported the completion of either or both of the following validation studies of
N H S N  CLABSI data reported from any IC U  during the reporting period: data quality assessment o f missing or implausible 
values along with state health departm ent followup with identified facilities, and detection o f outlier facilities along with state 
health departm ent followup with identified facilities. Yesa indicates that the state completed one or both of these activities 
and also conducted an audit o f medical records. Information on validation efforts was requested from all states, regardless of
the presence of a legislative mandate for the particular HAI type and location. Some states w ithout mandatory reporting of a 
given HAI to the state health departm ent have performed validation on N H S N  data that is voluntarily shared with them by 
facilities.
4. Facility-specific key percentiles were only calculated if >20 facilities had >1.0 predicted HAI during the reporting period. If  a 
single facility’s predicted num ber o f HAIs (e.g., CLABSI) was <1.0, a facility-specific SIR was neither calculated nor included 
in the determinations of the distribution of facility-specific SIRs.
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Table 3. State-specific Standardized Infection Ratios (SIRs) and facility-specific SIR summary measures, NH SN  facilities reporting during 2011










No. o f Infections 
Observed Predicted SIR
95% Cl for SIR 
Lower Upper
Facility-specific SIRs at Key Percentiles5
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6 17 14.797 1.149 0.669 1.840
15 53 68.156 0.778 0.582 1.017
10 32 54.307 0.589 0.403 0.832
8 31 70.557 0.439 0.298 0.624
342 1582 2642.387 0.599 0.570 0.629
8 77 106.198 0.725 0.572 0.906
1-4
3 19 16.821 1.130 0.680 1.764
4 5 13.480 0.371 0.120 0.866
44 160 332.285 0.482 0.410 0.562
29 178 175.414 1.015 0.871 1.175
5 10 14.491 0.690 0.331 1.269
12 0 6.499 0.000 0.568
1-4
30 153 244.011 0.627 0.532 0.735
19 200 252.358 0.793 0.686 0.910
9 27 40.534 0.666 0.439 0.969
9 31 38.316 0.809 0.550 1.148
21 31 55.436 0.559 0.380 0.794
11 86 125.101 0.687 0.550 0.849
12 28 73.578 0.381 0.253 0.550
1-4
28 43 116.789 0.368 0.266 0.496
8 0 1.982 0.000 1.861
7 16 36.616 0.437 0.250 0.710
10 38 106.612 0.356 0.252 0.489
6 5 27.219 0.184 0.060 0.429
0.000 0.153 0.510 0.846 1.378
0.000 0.128 0.332 0.571 0.874
0.004 0.231 0.481 0.898 1.682
Table 3. State-specific Standardized Infection Ratios (SIRs) and facility-specific SIR summary measures, NH SN  facilities reporting during 2011
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Lower Upper
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23 24.752 0.929 0.589 1.394
29 59.899 0.484 0.324 0.695
156 217.395 0.718 0.609 0.839
639 581.371 1.099 1.016 1.188
102 186.569 0.547 0.446 0.664
34 63.909 0.532 0.368 0.743
3 16.911 0.177 0.037 0.518
678 1374.314 0.493 0.457 0.532
79 51.438 1.536 1.216 1.914
0.000 0.463 1.002 1.349 1.767
0.000 0.189 0.400 0.716 1.264
306 440.312 0.695 0.619 0.777 0.000 0.299 0.545 0.921 1.833
14 21.330 0.656 0.359 1.101
215 319.276 0.673 0.586 0.770 0.000 0.000 0.481 0.906 1.274
71 120.516 0.589 0.460 0.743 0.000 0.056 0.548 0.977 1.345
144.936 0.938 0.787 1.110
37 59.505 0.622 0.438 0.857
64 128.580 0.498 0.383 0.636
12 73.803 0.163 0.084 0.284
0 2.383 0.000 1.548
0.000 0.000 0.138 0.609 0.944
All US 1,252 5,781 8998.281 0.642 0.626 0.659 0.000 0.156 0.484 0.863 1.372
Footnotes for Table 3c
1. D ata from all wards (for this table wards also include stepdown and specialty care areas [including hematology/oncology, bone 
marrow transplant]. This excludes LTAC locations [or facilities] and inpatient rehabilitation locations [or facilities]).
2. Yes indicates the presence of a state mandate to report CLABSI data from any ward to N H S N  at the beginning of 2011.
3. Yes indicates that the state health department reported the completion of either or both of the following validation studies 
of N H SN  CLABSI data reported from any ward location during the reporting period: data quality assessment o f missing or 
implausible values along with state health department followup with identified facilities, and detection of outlier facilities 
along with state health department followup with identified facilities. Yesa indicates that the state completed one or both
of these activities and also conducted an audit o f medical records. Information on validation efforts was requested from 
all states, regardless o f the presence of a legislative mandate for the particular HAI type and location. Some states without 
mandatory reporting of a given HAI to the state health departm ent have performed validation on N H SN  data that is 
voluntarily shared with them by facilities.
4. SIR data is only displayed for a state if >5 facilities reported during the reporting period.
5. Facility-specific key percentiles were only calculated if >20 facilities had >1.0 predicted HAI during the reporting period. If  a 
single facility’s predicted num ber o f HAIs (e.g., CLABSI) was <1.0, a facility-specific SIR was neither calculated nor included 
in the determinations of the distribution of facility-specific SIRs.
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Table 3. State-specific Standardized Infection Ratios (SIRs) and facility-specific SIR summary measures, NH SN  facilities reporting during 2011
3d. Central Line-associated Bloodstream Infections (CLABSI), Neonatal Intensive Care Units (NICUs)1
State State Any





No. o f Infections
Observed Predicted SIR
95% Cl for SIR 
Lower Uppe
Facility-specific SIRs at Key Percentiles5








































































81 65.490 1.237 0.982 1.537
19 52.169 0.364 0.219 0.569
26 38.929 0.668 0.436 0.979
173 375.872 0.460 0.394 0.534 0.000 0.000 0.368 0.834 1.333
25 45.428 0.550 0.356 0.812
14 25.544 0.548 0.300 0.920
11 37.167 0.296 0.148 0.530
136 185.442 0.733 0.615 0.868 0.000 0.380 0.560 0.959 1.490
121 122.708 0.986 0.818 1.178 0.213 0.586 0.975 1.242 1.798
11 29.761 0.370 0.185 0.661
8 11.543 0.693 0.299 1.366
79 166.648 0.474 0.375 0.591 0.000 0.244 0.382 0.625 1.033
52 73.299 0.709 0.530 0.930
15 25.542 0.587 0.328 0.969
38 35.117 1.082 0.766 1.485
68 75.929 0.896 0.695 1.135
31 41.464 0.748 0.508 1.061
43 67.008 0.642 0.464 0.864
59 91.847 0.642 0.489 0.829
11 25.136 0.438 0.218 0.783
49 93.849 0.522 0.386 0.690
34 26.014 1.307 0.905 1.826
2 8.569 0.233 0.028 0.843
Table 3. State-specific Standardized Infection Ratios (SIRs) and facility-specific SIR summary measures, NH SN  facilities reporting during 2011
3d. Central Line-associated Bloodstream Infections (CLABSI), Neonatal Intensive Care Units (NICUs)1
State State Any





No. o f Infections
Observed Predicted
49 127.782 0.383 0.284 0.507
9 10.667 0.844 0.386 1.602
11 14.376 0.765 0.382 1.369
95% Cl for SIR
SIR Lower Upper
Facility-specific SIRs at Key Percentiles5
























































































17 49.614 0.343 0.199 0.549
185 214.107 0.864 0.744 0.998
72 132.599 0.543 0.425 0.684
39 58.210 0.670 0.476 0.916
9 21.598 0.417 0.191 0.791
95 142.623 0.666 0.539 0.814




0.000 0.406 0.839 1.305 2.524
0.000 0.230 0.494 1.033 1.210
66 106.285 0.621 0.480 0.790
215 345.431 0.622 0.542 0.711
36 41.194 0.874 0.612 1.210
42 87.876 0.478 0.344 0.646
0.000 0.000 0.369 0.918 1.695
All US 928 2,198 3408.609 0.645 0.618 0.672 0.000 0.178 0.564 0.999 1.539
Footnotes for Table 3d
1. D ata from all N IC U  locations, including Level II/III and Level III nurseries. For purposes o f this report, both umbilical-line 
and central-line associated bloodstream infections are considered CLABSIs.
2. Yes indicates the presence of a state mandate to report CLABSI data from any N IC U  to N H S N  at the beginning of 2011.
3. Yes indicates that the state health department reported the completion of either or both of the following validation studies of 
N H S N  CLABSI data reported from any N IC U  during the reporting period: data quality assessment o f missing or implausible 
values along with state health departm ent followup with identified facilities, and detection o f outlier facilities along with state 
health departm ent followup with identified facilities. Yesa indicates that the state completed one or both of these activities and 
also conducted an audit o f medical records. Information on validation efforts was requested from all states, regardless o f the 
presence o f a legislative mandate for the particular HAI type and location. Some states w ithout mandatory reporting of a 
given HAI to the state health departm ent have performed validation on N H S N  data that is voluntarily shared with them by 
facilities.
4. SIR data is only displayed for a state if  >5 facilities reported during the reporting period.
5. Facility-specific key percentiles were only calculated if >20 facilities had >1.0 predicted HAI during the reporting period. If  a 
single facility’s predicted num ber o f HAIs (e.g., CLABSI) was <1.0, a facility-specific SIR was neither calculated nor included 
in the determinations of the distribution of facility-specific SIRs.
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Table 4. Summary o f State-specific Standardized Infection Ratios (SIRs) and confidence intervals,
Central Line-associated Bloodstream Infections (CLABSI), by location grouping1, 2011
All locations2 ICU3 Ward (non-critical care)4 N IC U 5
95% CI for SIR 95% CI for SIR 95% CI for SIR 95% CI for SIR
State SIR Lower Upper SIR Lower Upper SIR Lower Upper SIR Lower Upper
Alaska 0.716 0.472 1.042 0.676 0.324 1.244 1.149 0.669 1.840
Alabama 0.694 0.622 0.771 0.579 0.503 0.663 0.778 0.582 1.017 1.237 0.982 1.537
Arkansas 0.481 0.407 0.564 0.482 0.392 0.586 0.589 0.403 0.832 0.364 0.219 0.569
Arizona 0.575 0.508 0.648 0.591 0.515 0.676 0.439 0.298 0.624 0.668 0.436 0.979
California 0.565 0.545 0.587 0.540 0.508 0.574 0.599 0.570 0.629 0.460 0.394 0.534
Colorado 0.587 0.511 0.671 0.525 0.432 0.632 0.725 0.572 0.906 0.550 0.356 0.812
Connecticut 0.627 0.534 0.733 0.543 0.448 0.653 0.548 0.300 0.920
D.C. 0.693 0.573 0.831 0.758 0.607 0.935 1.130 0.680 1.764 0.296 0.148 0.530
Delaware 0.534 0.397 0.705 0.574 0.410 0.782 0.371 0.120 0.866
Florida 0.540 0.508 0.574 0.529 0.492 0.568 0.482 0.410 0.562 0.733 0.615 0.868
Georgia 0.816 0.757 0.880 0.715 0.646 0.790 1.015 0.871 1.175 0.986 0.818 1.178
Hawaii 0.258 0.160 0.394 0.126 0.054 0.248 0.690 0.331 1.269
Iowa 0.555 0.433 0.699 0.654 0.499 0.842 0.000 0.568 0.370 0.185 0.661
Idaho 0.428 0.277 0.632 0.343 0.192 0.566 0.693 0.299 1.366
Illinois 0.593 0.547 0.641 0.611 0.552 0.675 0.627 0.532 0.735 0.474 0.375 0.591
Indiana 0.580 0.526 0.639 0.416 0.353 0.485 0.793 0.686 0.910 0.709 0.530 0.930
Kansas 0.434 0.351 0.532 0.346 0.258 0.454 0.666 0.439 0.969 0.587 0.328 0.969
Kentucky 0.718 0.632 0.813 0.659 0.566 0.762 0.809 0.550 1.148 1.082 0.766 1.485
Louisiana 0.727 0.647 0.815 0.715 0.619 0.821 0.559 0.380 0.794 0.896 0.695 1.135
Massachusetts 0.562 0.502 0.627 0.504 0.437 0.579 0.687 0.550 0.849 0.748 0.508 1.061
Maryland 0.670 0.596 0.751 0.747 0.653 0.851 0.381 0.253 0.550 0.642 0.464 0.864
Maine 0.989 0.801 1.208 1.015 0.740 1.358
Michigan 0.362 0.323 0.404 0.322 0.281 0.369 0.368 0.266 0.496 0.642 0.489 0.829
Minnesota 0.403 0.330 0.489 0.403 0.325 0.494 0.000 1.861 0.438 0.218 0.783
Missouri 0.468 0.413 0.529 0.459 0.396 0.529 0.437 0.250 0.710 0.522 0.386 0.690
Mississippi 0.606 0.520 0.701 0.657 0.538 0.795 0.356 0.252 0.489 1.307 0.905 1.826
Montana 0.408 0.261 0.607 0.737 0.429 1.180 0.184 0.060 0.429 0.233 0.028 0.843
North Carolina 0.571 0.523 0.623 0.544 0.482 0.613 0.716 0.617 0.826 0.383 0.284 0.507
North Dakota 0.373 0.231 0.571 0.253 0.121 0.466 0.844 0.386 1.602
Nebraska 0.610 0.509 0.725 0.601 0.443 0.796 0.598 0.466 0.755 0.765 0.382 1.369
New Hampshire 0.640 0.446 0.891 0.553 0.358 0.817
New Jersey 0.728 0.660 0.801 0.690 0.617 0.769 0.929 0.589 1.394 0.872 0.688 1.090
New Mexico 0.523 0.416 0.648 0.523 0.378 0.704 0.484 0.324 0.695
Nevada 0.577 0.514 0.646 0.502 0.418 0.597 0.718 0.609 0.839 0.343 0.199 0.549
New York 0.837 0.796 0.878 0.698 0.651 0.749 1.099 1.016 1.188 0.864 0.744 0.998
Ohio 0.472 0.434 0.514 0.444 0.400 0.492 0.547 0.446 0.664 0.543 0.425 0.684
Oklahoma 0.514 0.444 0.592 0.474 0.394 0.567 0.532 0.368 0.743 0.670 0.476 0.916
Oregon 0.384 0.302 0.481 0.402 0.309 0.514 0.177 0.037 0.518 0.417 0.191 0.791
Pennsylvania 0.485 0.458 0.512 0.450 0.411 0.492 0.493 0.457 0.532 0.666 0.539 0.814
Puerto Rico 1.408 1.219 1.618 1.347 1.110 1.620 1.536 1.216 1.914 1.126 0.413 2.451
Rhode Island 0.710 0.530 0.931 0.717 0.518 0.965
South Carolina 0.706 0.648 0.768 0.657 0.564 0.761 0.695 0.619 0.777 1.057 0.796 1.376
South Dakota 0.443 0.297 0.636 0.358 0.179 0.641 0.656 0.359 1.101
Tennessee 0.699 0.647 0.755 0.732 0.660 0.811 0.673 0.586 0.770 0.621 0.480 0.790
Texas 0.559 0.526 0.593 0.541 0.504 0.580 0.589 0.460 0.743 0.622 0.542 0.711
Utah 0.673 0.554 0.809 0.536 0.409 0.690 0.874 0.612 1.210
Virginia 0.700 0.637 0.768 0.663 0.586 0.748 0.938 0.787 1.110 0.478 0.344 0.646
Vermont 0.246 0.090 0.535 0.303 0.111 0.660 0.000 . .
Washington 0.477 0.410 0.553 0.434 0.357 0.521 0.622 0.438 0.857 0.528 0.350 0.763
Wisconsin 0.574 0.506 0.649 0.595 0.507 0.693 0.498 0.383 0.636 0.664 0.448 0.948
West Virginia 0.460 0.379 0.553 0.585 0.471 0.717 0.163 0.084 0.284
Wyoming 0.289 0.060 0.846 0.376 0.078 1.098 0.000 1.548
All US 0.592 0.583 0.600 0.557 0.546 0.567 0.642 0.626 0.659 0.645 0.618 0.672 35
Footnotes for Table 4
1. SIR data is only displayed for a state if  >5 facilities reported during the reporting period.
2. D ata from all ICUs, wards (and other non-critical care locations), and NICUs. This excludes LTAC locations (or facilities) 
and inpatient rehabilitation locations (or facilities).
3. D ata from all ICUs; excludes wards (and other non-critical care locations), NICUs, LTAC locations (or facilities), and 
inpatient rehabilitation locations (or facilities).
4. D ata from all wards (for this table wards also include stepdown and specialty care areas [including hematology/oncology, bone
marrow transplant]. This excludes LTAC locations [or facilities] and inpatient rehabilitation locations [or facilities]).
5. D ata from all N IC U  locations, including Level II/III and Level III nurseries. For purposes o f this report, both umbilical-line 
and central-line associated bloodstream infections are considered CLABSIs.
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Table 5. Changes in State-specific Standardized Infection Ratios (SIRs), 2010 compared to 2011
Central Line-associated Bloodstream Infections (CLABSI), All Locations1
State













Alaska 0.589 0.716 No Change 0.723 3 No Change 0.840
Alabama 1.093 0.694 Decrease 0.000 67 Decrease 0.000
Arkansas 0.626 0.481 Decrease 0.047 21 No Change 0.204
Arizona 0.888 0.575 Decrease 0.000 21 Decrease 0.000
California 0.638 0.565 Decrease 0.000 335 Decrease 0.000
Colorado 0.658 0.587 No Change 0.286 50 No Change 0.286
Connecticut 0.677 0.627 No Change 0.562 30 No Change 0.562
D.C. 0.617 0.693 No Change 0.481 8 No Change 0.583
Delaware 0.863 0.534 Decrease 0.008 8 Decrease 0.008
Florida 0.679 0.540 Decrease 0.003 44 Decrease 0.038
Georgia 0.765 0.816 No Change 0.376 35 No Change 0.057
Hawaii 0.715 0.258 Decrease 0.003 7 Decrease 0.033
Iowa 0.440 0.555 No Change 0.433 24 No Change 0.202
Idaho 0.310 0.428 No Change 1.000 2 No Change 1.000
Illinois 0.684 0.593 Decrease 0.010 146 Decrease 0.010
Indiana 0.968 0.580 Decrease 0.000 32 Decrease 0.000
Kansas 0.595 0.434 No Change 0.060 13 No Change 0.068
Kentucky 0.656 0.718 No Change 0.481 21 Increase 0.032
Louisiana 0.819 0.727 No Change 0.340 30 No Change 0.840
Massachusetts 0.580 0.562 No Change 0.713 68 No Change 0.713
Maryland 0.931 0.670 Decrease 0.000 47 Decrease 0.000
Maine 0.958 0.989 No Change 0.869 5 No Change 0.405
Michigan 0.400 0.362 No Change 0.295 49 Decrease 0.023
Minnesota 0.532 0.403 No Change 0.353 3 No Change 0.287
Missouri 0.684 0.468 Decrease 0.002 10 No Change 0.097
Mississippi 0.783 0.606 Decrease 0.018 13 Decrease 0.008
Montana 0.481 0.408 No Change 0.636 10 No Change 0.876
North Carolina 0.655 0.571 No Change 0.086 36 No Change 0.204
North Dakota 0.203 0.373 No Change 0.340 2 No Change 0.752
Nebraska 0.870 0.610 Decrease 0.005 9 No Change 0.054
New Hampshire 0.539 0.640 No Change 0.527 24 No Change 0.527
New Jersey 0.803 0.728 No Change 0.154 72 No Change 0.154
New Mexico 0.456 0.523 No Change 0.469 18 No Change 0.415
Nevada 0.866 0.577 Decrease 0.000 17 Decrease 0.002
New York 0.865 0.837 No Change 0.362 177 No Change 0.401
Ohio 0.591 0.472 Decrease 0.010 26 Decrease 0.019
Oklahoma 0.544 0.514 No Change 0.630 49 No Change 0.554
Oregon 0.492 0.384 No Change 0.142 44 No Change 0.189
Pennsylvania 0.497 0.485 No Change 0.527 171 No Change 0.579
Puerto Rico
Rhode Island 1.171 0.710 No Change 0.093 4 No Change 0.194
South Carolina 0.857 0.706 Decrease 0.001 62 Decrease 0.001
South Dakota
Tennessee 0.870 0.699 Decrease 0.000 82 Decrease 0.000
Texas 0.609 0.559 No Change 0.238 80 No Change 0.061
Utah
Virginia 0.685 0.700 No Change 0.754 80 No Change 0.754
Vermont 0.782 0.246 Decrease 0.012 8 Decrease 0.012
Washington 0.464 0.477 No Change 0.829 62 No Change 0.829
Wisconsin 0.692 0.574 No Change 0.065 42 No Change 0.091
West Virginia 0.480 0.460 No Change 0.773 38 No Change 0.773
Wyoming
All US 0.677 0.592 Decrease 0.000 2210 Decrease 0.000 37
Footnotes for Table 5
1. SIRs are not reported for states with fewer than five facilities reporting CLABSI data to N H S N  in 2010 or 2011.
2. D ata from all ICUs, wards (and other non-critical care locations), and NICUs. This excludes LTAC locations (or facilities) 
and inpatient rehabilitation locations (or facilities).
3. Continuous reporters include all facilities w ith at least one location that reported any data for CLABSI during both 2010 and 
2011.
4. Adjusted by limiting analysis to only continuous reporters (e.g., facilities reporting for one m onth or more during 2010 that 
also reported during 2011).
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Table 6. Changes in National Standardized Infection Ratios (SIRs), 2010 compared to 2011, 
Central Line-associated Bloodstream Infections (CLABSI), Catheter-associated 
Urinary Tract Infections (CAUTI), and Surgical Site Infections (SSI)8













CLABSI, all locations3 0.677 0.592 Decrease 0.000 2,210 Decrease 0.000
CLABSI, ICU4 0.654 0.557 Decrease 0.000 2,117 Decrease 0.000
CLABSI, Ward5 0.711 0.642 Decrease 0.000 871 Decrease 0.000
CLABSI, N IC U 6 0.697 0.645 Decrease 0.023 500 Decrease 0.034
CAUTI, all locations7 0.937 0.930 No Change 0.568 923 Decrease 0.001
CAUTI, ICU4 0.972 0.989 No Change 0.286 760 No Change 0.127
CAUTI, Ward5 0.883 0.845 Decrease 0.046 550 Decrease 0.000
SSI, combined SCIP procedures8 0.927 0.827 Decrease 0.000 1,336 Decrease 0.001
SSI, Hip arthroplasty 0.970 0.896 Decrease 0.050 923 No change 0.244
SSI, Knee arthroplasty 0.941 0.857 Decrease 0.020 929 Decrease 0.046
SSI, Coronary artery bypass graft9 0.844 0.779 No change 0.105 412 No change 0.281
SSI, Cardiac surgery 0.847 0.698 No change 0.123 156 No change 0.650
SSI, Peripheral vascular bypass surgery 0.907 0.745 No change 0.271 42 No change 0.408
SSI, Abdominal aortic aneurysm repair 0.653 0.543 No change 0.796 29 No change 0.783
SSI, Colon surgery 0.903 0.796 Decrease 0.002 441 No change 1.000
SSI, Rectal surgery 1.044 0.744 No change 0.146 18 No change 1.000
SSI, Abdominal hysterectomy 1.011 0.834 Decrease 0.004 559 No change 0.052
SSI, Vaginal hysterectomy 1.158 0.867 Decrease 0.044 201 No change 0.758
Footnotes for Table 6
1. Continuous reporters include all facilities that reported any CLABSI or CAUTI data for any location during both 2010 and 
2011 or SSI data for any of the 10 SCIP procedures during both 2010 and 2011.
2. Adjusted by limiting analysis to only continuous reporters, i.e., facilities reporting at least 1 location or procedure for 1 m onth
or more during 2010 that also reported during 2011.
3. D ata from all ICUs, wards (and other non-critical care locations), and NICUs. This excludes LTAC locations (or facilities)
and inpatient rehabilitation locations (or facilities).
4. D ata from all ICUs; excludes wards (and other non-critical care locations), NICUs, LTAC locations (or facilities), and
inpatient rehabilitation locations (or facilities).
5. D ata from all wards (for this table wards also include stepdown and specialty care areas [including hematology/oncology, bone 
marrow transplant]. This excludes LTAC locations [or facilities] and inpatient rehabilitation locations [or facilities]).
6. D ata from all N IC U  locations, including Level II/III and Level III nurseries. For purposes o f this report, both umbilical-line
and central-line associated bloodstream infections are considered CLABSIs.
7. D ata from all ICUs and wards (and other non-critical care locations). This excludes NICUs, LTAC locations (or facilities) and 
inpatient rehabilitation locations (or facilities).
8. SSIs included are those following select surgical procedures approximating procedures covered by SCIP, using N H SN  
surgical procedure categorizations that were classified as deep incisional or organ/space, and were detected upon admission or 
readmission. (Specific N H SN  procedures and the corresponding SCIP procedures are listed in Appendix A.)
9. Coronary artery bypass graft includes procedures with either chest only or chest and donor site incisions.
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Appendix A.
Surgical Care Im provement Project (SCIP) Procedures, N H S N  Procedure Categories Approximating SCIP 
Procedures, and Validated Parameters for Surgical Site Infection Risk Models in N H SN
SCIP Procedure NH SN Procedure Category Validated Parameters for Risk Model
Vascular
A bdom inal aortic aneurysm repair duration o f  procedure, w ound class
Peripheral vascular bypass surgery age, ASA, duration  o f  procedure, medical school affiliation
C oronary artery bypass 
graft
C oronary artery bypass graft w ith 
bo th  chest and donor site incisions; 
C oronary artery bypass graft w ith 
chest incision only
age, ASA, duration  o f  procedure, 
gender, medical school affiliation, age 
gender (interaction)
O ther cardiac Cardiac surgery age, duration o f  procedure, emergency
C olon surgery
C olon surgery
age, ASA, duration, endoscope, 
medical school affiliation, hospital bed 
size, w ound class
Rectal surgery duration o f procedure, gender, hospital bed size
H ip arthroplasty H ip arthroplasty (both prim ary and revision hip arthroplasties)
total/partial/revision, age, anesthesia, 
ASA, duration o f  procedure, medical 
school affiliation, hospital bed size, 
traum a
Abdom inal
hysterectomy A bdom inal hysterectomy
age, ASA, duration  o f  procedure, 
hospital bed size
Knee arthroplasty Knee arthroplasty
age, ASA, duration  o f  procedure, 
gender, medical school affiliation, 
hospital bed size, traum a, revision
Vaginal hysterectomy Vaginal hysterectom y age, duration  o f  procedure, medical school affiliation
Adapted from M u Y, Edwards JR, H oran TC , Berrios-Torres SI, Fridkin SK. Improving risk-adjusted 
measures o f surgical site infection for the National Healthcare Safety Network. Infect Control Hosp 
Epidemiol 2011 Oct; 32(10):970-86.
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